Bovine Coronavirus Respiratory Disease

Overview and Taxonomy of Bovine Coronavirus Respiratory Disease

Bovine coronavirus (BCoV) is a globally significant, enveloped, positive-sense single-stranded RNA virus belonging to the family Coronaviridae, subfamily Orthocoronavirinae, genus Betacoronavirus, and subgenus Embecovirus [28, 33]. This taxonomic placement aligns BCoV within the same genus as human coronaviruses OC43 (HCoV-OC43) and HKU1, as well as the highly pathogenic severe acute respiratory syndrome coronaviruses (SARS-CoV, SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV), underscoring its relevance to both veterinary and public health frameworks [9, 33]. The World Organisation for Animal Health (WOAH) recognizes BCoV as a causative agent of significant economic losses in the global cattle industry, contributing to neonatal calf diarrhea, winter dysentery in adult cattle, and, critically, the bovine respiratory disease complex (BRDC) [26, 28]. The virus is endemic in cattle populations worldwide, with seroprevalence rates often exceeding 70% in many regions, indicating widespread exposure and persistent circulation [35, 37].

Taxonomic Classification and Genetic Lineages

BCoV is classified within the species Betacoronavirus 1, which also includes HCoV-OC43 and several other animal coronaviruses, reflecting a close evolutionary relationship and potential for cross-species transmission [9, 20, 33]. The viral genome, approximately 31 kb in length, encodes four major structural proteins: the spike (S) glycoprotein, the hemagglutinin-esterase (HE) protein, the membrane (M) protein, and the nucleocapsid (N) protein, along with 16 non-structural proteins (nsps) involved in replication and immune evasion [18, 19, 33]. The S protein, particularly its hypervariable region, is a primary determinant of antigenic diversity, tissue tropism, and host immune response, making it a key target for phylogenetic classification and vaccine development [2, 4, 37].

Phylogenetic analyses based on complete genome and S gene sequences have delineated BCoV strains into two major genetic groups: GI and GII, with further subdivision into multiple clades and genotypes [6, 22, 37]. Historically, older prototype strains such as Mebus and Nebraska were classified within GI, while contemporary circulating strains predominantly belong to GII, which is further divided into GIIa and GIIb subgroups [6, 22, 34]. The GIIb genotype, in particular, has become dominant in Asia and the Americas, including strains isolated in China, South Korea, Japan, and Brazil [4, 6, 22, 34]. A novel genotype, designated #15, was recently identified in Brazil based on S1 gene sequencing, highlighting the ongoing evolutionary diversification of BCoV [4]. In Japan, a distinct lineage has emerged since 2005, with G3 and G4 genotypes co-circulating in regions such as Chiba Prefecture, challenging earlier assumptions that the G3 genotype had become extinct [2]. This genetic plasticity is driven by high mutation rates and recombination events, particularly within the S gene, which undergoes episodic positive selection pressure likely imposed by host immunity [37].

The Respiratory Phenotype: A Distinct Pathological Entity

Historically, BCoV was primarily recognized as an enteric pathogen causing neonatal calf diarrhea and winter dysentery in adult cattle. However, a substantial and growing body of evidence has firmly established its role as a primary respiratory pathogen, capable of inducing clinical disease and pathological lesions in the upper and lower respiratory tracts of cattle of all ages [5, 17, 24, 38]. The respiratory form of BCoV infection is now considered a critical component of the bovine respiratory disease complex (BRDC), a multifactorial syndrome involving viral-bacterial synergism, environmental stressors, and host factors [1, 10, 23].

The virus exhibits a broad tissue tropism, with the respiratory tract serving as a primary site of entry and replication following intranasal exposure [17, 31]. Experimental challenge studies have demonstrated that BCoV can infect epithelial cells lining the nasal passages, trachea, bronchi, bronchioles, and alveoli, leading to characteristic histopathological lesions [5, 17]. These lesions include tracheal epithelial attenuation, loss of cilia, and infiltration of inflammatory cells, as well as interstitial pneumonia characterized by thickening of the interalveolar septa due to lymphocyte infiltration and fibroblast proliferation [1, 5, 10]. In severe cases, particularly those involving co-infection with bacterial pathogens such as Pasteurella multocida or Mannheimia haemolytica, a suppurative bronchopneumonia with neutrophilic exudate can develop, compounding the respiratory compromise [1, 23].

The direct detection of BCoV antigen within respiratory lesions, confirmed by immunohistochemistry (IHC) and RNA in situ hybridization (ISH), provides definitive evidence of its causal role in respiratory pathology [5, 17]. Using RNAscope ISH technology, Rahe et al. (2022) demonstrated BCoV RNA within respiratory epithelial cells of the trachea and lower airways in calves with BRD, often in association with epithelial attenuation and inflammation, thereby confirming that the virus is not merely a bystander but an active participant in disease pathogenesis [5]. Furthermore, the virus can be isolated from bronchoalveolar lavage (BAL) fluid and lung tissue of infected animals, and viral shedding in nasal secretions can reach high titers, facilitating transmission [6, 17].

Epidemiology and Global Distribution of Respiratory BCoV

BCoV is distributed globally, with respiratory infections reported across all major cattle-producing continents, including North America, South America, Europe, Asia, and Australia [2, 4, 7, 12, 26, 32]. The prevalence of BCoV in cattle with respiratory disease varies widely depending on geographic region, diagnostic methodology, and the population studied, but consistently underscores its importance. In a large-scale meta-analysis of studies from China, the overall prevalence of BCoV was estimated at 30.8%, with the highest rates observed in southern China (60.5%) [26]. In Japan, a molecular survey from 2016-2018 found that 21.2% of cattle with respiratory disease were BCoV-positive, with viral loads 4.7 times higher in symptomatic animals compared to asymptomatic carriers [27]. A more recent survey in Chiba Prefecture, Japan, reported a striking 43.8% positivity rate using real-time RT-PCR on nasal swabs from cattle with respiratory symptoms [2].

In Europe, BCoV is frequently the most commonly detected virus in BRD outbreaks. A Belgian study of 128 acute respiratory outbreaks found BCoV in 38.4% of cases, making it the most prevalent viral agent, surpassing bovine respiratory syncytial virus (BRSV) at 29.4% [39]. Similarly, in Poland, BCoV was detected in 32.43% of herds with BRD symptoms [15], and a case report from eastern Poland confirmed BCoV as the sole etiological agent in a fatal outbreak of respiratory disease in newly introduced calves [3]. In North America, BCoV is consistently identified in feedlot cattle, with prevalence rates on arrival at feedlots ranging from 45.2% in western Canada to high levels in the United States [25, 29, 30]. In Australia, metatranscriptomic studies have revealed BCoV as one of the most abundant RNA viruses in the respiratory tract of feedlot cattle, alongside bovine nidovirus and influenza D virus [32].

The epidemiology of respiratory BCoV is characterized by seasonal patterns, with outbreaks more common during the colder months, and by its association with management practices such as transport, commingling, and introduction of new animals into a herd [13, 16, 21]. Transport stress, in particular, is a well-documented risk factor, as it can precipitate viral shedding and clinical disease in latently infected or recently exposed animals [16, 21]. The virus is highly contagious and spreads via direct contact, aerosol, and fomites, with nasal shedding detectable for up to 10-14 days post-infection [6, 17].

Co-infection Dynamics and the BRDC Paradigm

BCoV rarely acts alone in the pathogenesis of BRDC. Instead, it frequently participates in complex polymicrobial interactions with other viruses and bacteria, which can dramatically exacerbate disease severity [1, 10, 23]. The virus is often detected in co-infections with Pasteurella multocida, Mannheimia haemolytica, Histophilus somni, Mycoplasma bovis, and other respiratory viruses such as BVDV, BRSV, and BPIV-3 [1, 4, 8, 11, 15, 39]. A hierarchical cluster analysis of 156 BRD outbreaks identified two distinct epidemiological patterns: one characterized by a high frequency of viral involvement (including BCoV) in young, pre-weaned calves during winter, and another where bacterial pathogens predominated in older, fattening cattle [13].

The mechanisms underlying viral-bacterial synergism are multifaceted. BCoV infection of respiratory epithelial cells has been shown to upregulate cellular adhesion molecules, specifically intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAF-R), which serve as receptors for bacterial adherence [23]. This upregulation enhances the binding of Pasteurella multocida to both upper and lower respiratory tract epithelial cells, thereby facilitating secondary bacterial colonization and pneumonia [23]. Additionally, BCoV can induce immunosuppression through the degradation of TNF receptor-associated factor 3 (TRAF3) via its non-structural protein 14 (nsp14), thereby inhibiting interferon production and creating a permissive environment for bacterial proliferation [19]. Sequential infection with BVDV followed by BCoV has also been shown to potentiate lung lesion severity, suggesting that prior viral exposure can prime the respiratory tract for more severe BCoV-mediated pathology [10].

Zoonotic Considerations and Public Health Context

From a public health perspective, BCoV is of notable interest due to its close genetic and antigenic relationship with HCoV-OC43, a common cause of the common cold in humans [9, 20, 33]. The two viruses share 96.4-97.1% nucleotide identity in the RNA-dependent RNA polymerase (RdRp) gene, and the N protein epitope 380YQQQDG385 is 100% conserved between BCoV, HCoV-OC43, and canine respiratory coronavirus (CRCoV), suggesting a common evolutionary origin and potential for cross-species transmission [9, 20]. Historical evidence indicates that HCoV-OC43 may have emerged from a bovine coronavirus ancestor following a zoonotic spillover event in the 19th century [33]. While contemporary BCoV is not considered a major zoonotic threat, its ability to infect a wide range of ruminant species, including alpacas, llamas, and deer, and its genetic plasticity, warrant continued surveillance under the One Health framework [33, 36]. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have highlighted the importance of monitoring animal coronaviruses as potential sources of future human epidemics, a lesson underscored by the SARS-CoV-2 pandemic [14, 33].

Molecular Pathogenesis of Bovine Coronavirus in the Respiratory Tract

Viral Entry and Cellular Tropism in the Respiratory Epithelium

The molecular pathogenesis of bovine coronavirus (BCoV) in the respiratory tract initiates with the virus's remarkable capacity to bind and enter epithelial cells lining both the upper and lower airways. BCoV, a member of the Betacoronavirus genus within the family Coronaviridae, employs its trimeric spike (S) glycoprotein as the primary determinant of cell tropism. The S1 subunit, particularly the hypervariable region, mediates attachment to host cell receptors. Although the precise receptor for BCoV in bovine respiratory tissues remains incompletely defined, compelling evidence indicates that the virus engages sialic acid moieties on the surface of respiratory epithelial cells, a mechanism shared with other betacoronaviruses such as human coronavirus OC43 [28]. The hemagglutinin-esterase (HE) glycoprotein, a unique feature of embecoviruses, further facilitates this interaction by acting as a lectin that binds to O-acetylated sialic acids, while its esterase activity cleaves these receptors, allowing viral release and preventing superinfection [33]. This dual-receptor binding motif, whereby the S protein mediates primary attachment and the HE protein modulates sialic acid recognition, is critical for BCoV's ability to establish infection in the respiratory microenvironment.

Experimental intranasal inoculation studies have definitively demonstrated that BCoV exhibits broad tissue tropism within the respiratory tract, with primary replication occurring in the nasal epithelium, trachea, and bronchi, followed by dissemination to the lungs [31]. Notably, viral RNA appears in nasal swabs before fecal shedding, confirming that the respiratory epithelium serves as the initial site of viral replication, even in isolates derived from enteric cases [31]. The virus demonstrates robust susceptibility in both upper respiratory tract (URT) and lower respiratory tract (LRT) epithelial cells. In vitro infection of bovine epithelial cells derived from trachea, bronchus, and lung reveals that all these cell types are permissive to BCoV infection, with the virus upregulating the expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAF-R), both of which are critical adhesion molecules exploited by bacterial pathogens such as Pasteurella multocida [23]. This molecular interplay is fundamentally important to the pathogenesis of bovine respiratory disease complex (BRDC), as it establishes a mechanistic link between primary viral infection and secondary bacterial colonization. The ability of BCoV to infect cells throughout the respiratory tract, from the nasal mucosa to the pulmonary parenchyma, positions it as a true respiratory pathogen, a role that has been historically underappreciated but is now supported by a substantial and growing body of evidence [5, 17].

Modulation of Host Cell Signaling and Immune Evasion

Once BCoV gains entry into respiratory epithelial cells, the virus orchestrates a sophisticated reprogramming of host cellular machinery to facilitate its replication while simultaneously subverting innate immune responses. The viral genome, the largest among RNA viruses at approximately 31 kb, encodes 16 non-structural proteins (nsps) that are essential for replication complex formation and host immune modulation [33]. Among these, nsp14, a bifunctional enzyme possessing exoribonuclease (ExoN) and N7-methyltransferase activities, plays a particularly critical role in pathogenesis. Recent investigations have elucidated that BCoV nsp14 acts as a potent antagonist of the host interferon (IFN) response by specifically targeting TNF receptor-associated factor 3 (TRAF3) for degradation [19]. TRAF3 is a central adaptor molecule in the signaling cascades that lead to the activation of interferon regulatory factor 3 (IRF3) and subsequent production of IFN-β. Nsp14 achieves this degradation through a dual mechanism, coordinating both the ubiquitin-proteasome pathway and the autophagy-lysosomal pathway. Specifically, nsp14 recruits the E3 ubiquitin ligase STUB1 to ubiquitinate TRAF3, which is then recognized by the cargo receptor Tollip and delivered for selective autophagic degradation [19]. RNA interference-mediated knockdown of STUB1 or Tollip prevents nsp14-mediated TRAF3 degradation, restoring IFN-β production and inhibiting viral replication. This represents a novel immune evasion strategy that has significant implications for respiratory pathogenesis, as the suppression of the type I interferon response in the respiratory mucosa allows BCoV to replicate to high titers while simultaneously creating a permissive environment for secondary bacterial invaders.

Complementing this immune evasion strategy, transcriptomic and proteomic analyses of BCoV-infected Madin-Darby bovine kidney (MDBK) cells have revealed profound alterations in host gene expression that extend well beyond interferon signaling. At 24 and 48 hours post-infection, thousands of differentially expressed genes and hundreds of differentially expressed proteins are identified, with significant enrichment in pathways related to metabolism, endocytosis, apoptosis, and protein processing in the endoplasmic reticulum [18]. Critically, BCoV infection leads to the downregulation of complement component C3 at both the mRNA and protein levels, suggesting that the virus actively suppresses complement-mediated antiviral responses [18]. The upregulation of genes associated with the MAPK, TNF, and Ras signaling pathways indicates that BCoV manipulates stress response and inflammatory signaling to its advantage, while the downregulation of the Wnt signaling pathway may contribute to dysregulated epithelial repair mechanisms in the airways [18]. Furthermore, the virus modulates the activity of protein kinase CK2, a serine/threonine kinase involved in numerous cellular processes including cell cycle control and apoptosis. Pharmacological inhibition of CK2 with the peptide CIGB-325 reduces BCoV-induced cytopathic effects and viral plaque formation, with the inhibitor physically interacting with the nucleocapsid (N) protein and interfering with its function [41]. These findings underscore that BCoV pathogenesis is not merely a consequence of cytolytic replication but rather a complex interplay of host cellular reprogramming and targeted immune subversion.

Cytopathic Effects and Pathological Lesions in Respiratory Tissues

The culmination of BCoV's molecular interactions with the respiratory epithelium is the development of characteristic histopathological lesions that define the virus's contribution to BRD. The hallmark lesion associated with BCoV infection in the lower respiratory tract is interstitial pneumonia, characterized by moderate infiltration of lymphocytes and increased numbers of fibroblasts within the interalveolar septa and the stromal tissues surrounding bronchioles and bronchi [1]. This pattern of inflammation is distinct from the suppurative bronchopneumonia typically associated with primary bacterial infections, though in cases of co-infection with bacterial pathogens such as Pasteurella multocida, overlapping lesion patterns emerge, with cranioventral lobes exhibiting neutrophilic exudate superimposed on the interstitial changes [1]. Immunohistochemical analysis demonstrates that BCoV antigen colocalizes precisely with these lesions, being detected within epithelial cells and cellular debris in the lumina of alveoli, bronchi, and bronchioles, providing direct evidence of the virus's etiological role in the observed pathology [1, 5].

At the gross pathological level, BCoV-positive cases display variable degrees of consolidation of the cranioventral lung lobes, often accompanied by non-collapsed caudodorsal lobes, congestion, and emphysema [1]. The severe end of the pathological spectrum is exemplified by cases of fatal interstitial pneumonia, where BCoV has been identified as the sole pathogen in outbreaks of acute respiratory distress. In such instances, animals present with severe dyspnea and gasping breath, with death occurring within 3 to 4 days of symptom onset. Necropsy reveals extensive pulmonary involvement, and viral RNA is detectable not only in lung tissue but also in mediastinal lymph nodes, small intestine, liver, and even placenta, indicating systemic dissemination [38, 42]. The severity of these lesions underscores that BCoV is capable of inducing a fulminant respiratory syndrome that is functionally analogous to the severe acute respiratory syndromes caused by highly pathogenic coronaviruses in humans.

The detection of BCoV within respiratory lesions has been significantly advanced by the application of RNAscope in situ hybridization (ISH), which offers superior sensitivity compared to conventional immunohistochemistry. Using this technique, BCoV RNA is consistently detected within respiratory epithelial cells of the trachea and lower airways, with tracheal epithelial attenuation being a common finding [5]. This epithelial damage is not merely a bystander effect of inflammation but rather a direct consequence of viral replication, as demonstrated by the temporal correlation between viral load and histopathological severity. In experimental infection models, calves challenged intranasally with virulent BCoV develop detectable viral RNA in bronchoalveolar lavage fluid and exhibit histopathological lesions in both upper and lower respiratory tissues, with viral antigen confirmed by immunohistochemistry as early as 4 days post-challenge [17]. The deletion of three amino acids in the serine-rich region of the N protein has been associated with particularly severe respiratory and digestive disease, suggesting that this region may influence viral pathogenicity through effects on RNA packaging or modulation of the host immune response [6]. The N protein itself, being highly conserved and immunogenic, is a key target for early diagnosis and vaccine development, with linear B-cell epitopes such as ³⁸⁰YQQQDG³⁸⁵ showing remarkable conservation across BCoV strains and 100% identity with human coronavirus OC43 and canine respiratory coronavirus, highlighting potential interspecies transmission pathways [20].

Viral-Bacterial Synergy and the Role of Co-infection in Exacerbating Respiratory Disease

Perhaps the most clinically relevant aspect of BCoV respiratory pathogenesis is its capacity to act as a gateway pathogen that predisposes the respiratory tract to secondary bacterial infections, a cornerstone of the BRDC paradigm. The molecular basis for this synergy has been elegantly elucidated through studies examining bacterial adherence following viral infection. BCoV infection of bovine epithelial cells from both the upper and lower respiratory tract results in the significant upregulation of ICAM-1 and PAF-R, two cellular receptors that are exploited by Pasteurella multocida for adherence [23]. This virus-induced enhancement of bacterial adhesion represents a critical mechanism by which a primary viral infection, which may be mild or subclinical in itself, can precipitate severe bacterial bronchopneumonia. Notably, this pattern of enhanced bacterial adherence following BCoV infection is distinct from that observed with bovine respiratory syncytial virus (BRSV), which differentially modulates bacterial adherence depending on whether cells are derived from the upper or lower respiratory tract [23]. This distinction underscores the unique pathogenic role of BCoV within the viral consortium contributing to BRDC.

Epidemiological studies corroborate these molecular findings, demonstrating strong associations between BCoV detection and the presence of bacterial pathogens in clinical cases. In a comprehensive analysis of BRD outbreaks, BCoV was the most frequently isolated virus (38.4% of outbreaks), and its detection was significantly associated with the presence of Mannheimia haemolytica (odds ratio = 2.8) and increasing herd size [39]. Similarly, in dairy calves from high-production herds, BCoV was detected at a higher frequency (56%) than bacterial pathogens such as Pasteurella multocida (39.8%) and M. haemolytica (33.1%), and these pathogens were commonly detected together in both symptomatic and asymptomatic animals [4]. The sequential exposure model provides further evidence for synergism: calves inoculated with bovine viral diarrhea virus (BVDV) followed by BCoV 6 days later developed the most pronounced lung lesions, characterized by moderate to severe interstitial pneumonia with extensive BCoV antigen distribution [10]. This timing-dependent potentiation indicates that prior immunosuppression or epithelial damage from one viral infection can dramatically enhance the pathogenic potential of BCoV, highlighting the complex viral-viral interactions that occur within the respiratory tract.

The clinical consequences of these synergistic interactions are significant. Calves that are seropositive for BCoV upon arrival at veal facilities have reduced odds of developing lung consolidation (odds ratio = 0.37), suggesting that naturally acquired immunity or maternally derived antibodies provide meaningful protection against the virus's contribution to respiratory disease [40]. Conversely, the detection of BCoV in nasal swabs at the time of BRD outbreaks, often in co-detection with Histophilus somni, indicates that active viral replication is contributing to disease pathogenesis even when clinical signs are already apparent [11]. The persistence and recurrence of BCoV shedding episodes in animals treated for BRD further complicate the clinical picture, as viral recrudescence may drive ongoing inflammation and bacterial colonization despite antimicrobial therapy [11]. The World Organisation for Animal Health (WOAH) recognizes the global economic impact of BRD, and the molecular evidence now clearly establishes BCoV as a primary viral trigger within this complex, warranting its consideration in diagnostic and control strategies worldwide. The virus's ability to damage the respiratory epithelium, suppress local immune responses through mechanisms such as TRAF3 degradation [19] and complement inhibition [18], and simultaneously upregulate bacterial adhesion receptors [23] creates a perfect storm for the development of severe, polymicrobial respiratory disease.

Epidemiology and Global Distribution of Bovine Coronavirus Respiratory Infections

Global Prevalence Patterns and Geographic Variation

Bovine coronavirus (BCoV) respiratory infections represent a pervasive and economically significant component of the bovine respiratory disease complex (BRDC) across virtually all cattle-producing regions worldwide. The true extent of BCoV involvement in respiratory disease has been historically underestimated, as early diagnostic efforts focused predominantly on enteric manifestations. However, a growing body of molecular epidemiological evidence over the past decade has fundamentally reshaped our understanding of BCoV as a primary respiratory pathogen with a truly global distribution pattern that mirrors international cattle trade networks and husbandry practices [28, 33]. The World Organisation for Animal Health (WOAH) recognizes BCoV as a significant contributor to BRDC, although standardized global surveillance programs remain heterogeneous in scope and methodology.

Prevalence rates vary dramatically across geographic regions and study populations, ranging from less than 1% in certain Indian calf cohorts to over 56% in Brazilian dairy heifer operations [1, 4]. In the Indian subcontinent, a recent investigation of 406 weaner calves (166 cattle, 240 buffaloes) with respiratory distress revealed only 0.98% BCoV occurrence confirmed by RT-PCR and immunohistochemistry, suggesting either low circulation in that specific population or potential limitations in detection timing relative to disease onset [1]. This contrasts sharply with findings from high-production dairy systems in Brazil, where BCoV was detected in 56% (93/166) of heifer calves from 10 herds, a frequency exceeding that of Pasteurella multocida (39.8%) and Mannheimia haemolytica (33.1%) [4]. Such disparities underscore the critical influence of husbandry intensity, geographic location, and diagnostic methodology on reported prevalence.

North American feedlot and dairy operations consistently demonstrate substantial BCoV circulation. In western Canadian feedlots, metagenomic sequencing of deep nasal swabs collected upon arrival identified BCoV as the most prevalent virus, detected in 45.2% (140/310) of cattle, surpassing bovine rhinitis B virus (21.9%) and enterovirus E (19.6%) [25]. Similarly, a seminal study coupling histologic evaluation with RNAscope in situ hybridization in 104 calves with BRD confirmed BCoV detection in respiratory epithelium, providing definitive evidence of the virus’s role in lower respiratory tract pathology [5]. In the United States, genome-wide association analyses across dairy calves (n=1,938 from California, n=647 from New Mexico) and feedlot cattle (n=915 from Colorado, n=934 from Washington) revealed heritability estimates for BCoV infection of 0.11 in feedlot cattle, indicating significant genetic components to susceptibility that may influence regional prevalence patterns [50].

European epidemiological surveys reveal equally substantial BCoV burdens. In Belgium, a cross-sectional study of 128 BRD outbreaks (2016–2018) identified BCoV as the most frequently isolated virus, present in 38.4% of outbreaks, surpassing bovine respiratory syncytial virus (BRSV) at 29.4% [39]. Polish investigations of 296 calves from 74 dairy herds demonstrated BCoV in 32.43% of herds using multiplex PCR, with bacterial coinfections comprising 56.7% of all detections [15]. In Slovenia, genetic characterization of 24 BCoV-positive samples from cattle with respiratory disease revealed close genetic relatedness (96.4–97.1% nucleotide identity) to human coronavirus OC43, highlighting the betacoronavirus genus interconnectedness and potential zoonotic implications [9]. The Norwegian control program, a pioneering population-based approach, has demonstrated that voluntary biosecurity measures and antibody testing can reduce BCoV prevalence at the national level, with herd-level probability-of-freedom estimates providing dynamic surveillance tools [43, 45].

East Asian epidemiological patterns reveal both high prevalence and unique genotypic distributions. In Japan, surveys from Chiba Prefecture (2020–2022) detected BCoV RNA in 43.8% (46/105) of cattle with respiratory symptoms, with phylogenetic analysis revealing coexistence of Japan G3 and G4 genotypes, contradicting earlier assumptions that G3 had become extinct [2]. A broader Japanese survey from 2016–2018 found 21.2% (58/273) of respiratory-diseased cattle positive, with viral loads 4.7 times higher than in asymptomatic animals, suggesting a dose-response relationship between viral burden and clinical manifestation [27]. In China, a comprehensive systematic review and meta-analysis encompassing 57 articles and 15,838 samples reported an overall BCoV prevalence of 30.8%, with striking geographic variation from 60.5% in South China to 15.6% in Central China, and identified sample source, detection method, breeding system, and diarrheal status as significant risk factors [26]. Within China, the GIIb genotype predominates, and recent isolates such as BCoV NXWZ2310, harboring a three-amino-acid deletion in the serine-rich region of the N gene, demonstrate enhanced pathogenicity causing both respiratory and digestive disease with nasal shedding reaching 10^6.2 copies/mL [6, 22].

Australian feedlot systems have more recently recognized BCoV as a significant respiratory contributor. Metatranscriptomic analyses of nasal swabs from Australian feedlot cattle revealed high abundance of BCoV alongside bovine nidovirus and influenza D virus, with complete genome sequences confirming BCoV’s presence in BRD-affected animals [32, 46]. This aligns with broader recognition that BCoV, previously considered primarily enteric, is an emerging respiratory pathogen in Australian production systems [32, 47].

Ecological and Management Risk Factors for BCoV Respiratory Infection

The epidemiological landscape of BCoV respiratory infections is profoundly shaped by a complex interplay of host, environmental, and management factors that modulate transmission dynamics and disease expression. The virus exhibits remarkable environmental stability and is transmitted via direct contact, aerosolized respiratory secretions, and fomite contamination, with respiratory shedding preceding enteric shedding in experimentally infected calves, indicating that the respiratory tract serves as the initial replication site [17, 31]. Experimental intranasal inoculation studies have demonstrated that BCoV initiates replication in respiratory epithelia before disseminating to the digestive tract, establishing a temporal framework for understanding transmission patterns in field settings [31]. This tissue tropism has critical epidemiological implications: calves shedding virus nasally may contaminate communal feeding and watering equipment, facilitating rapid within-herd spread before clinical signs become apparent.

Transportation stress represents one of the most potent epidemiological amplifiers of BCoV infection. A longitudinal study of 169 Limousine beef steers transported from France to Italy documented that while no animals displayed clinical signs at loading (T0), the number of animals positive for BCoV increased dramatically by 4 days after arrival (T1), with coinfection rates surging from 16.0% to 82.8% (p < 0.001) [16]. This phenomenon is not limited to European contexts; imported cattle in southern Italy showed BCoV as one of the most frequently identified pathogens, alongside Histophilus somni, with a statistically significant association between transport-related stress and pathogen detection [21]. The physiological mechanisms underlying this amplification likely involve stress-induced immunosuppression mediated by glucocorticoid release, which enhances viral replication and shedding, combined with the commingling of animals from diverse immunological backgrounds that facilitates introduction of novel BCoV strains into naive populations [16, 21].

Herd-level demographic factors substantially influence BCoV respiratory epidemiology. Increasing herd size is an independent risk factor for BCoV detection, with each increment of 100 animals associated with an odds ratio of 1.3 (95% CI: 1.0–1.8) for BCoV positivity [39]. This likely reflects both increased probability of viral introduction through animal movements and higher within-herd contact rates that facilitate transmission. Age stratification reveals that preweaning calves, particularly those younger than 5 months, are disproportionately affected by viral-associated BRD, with cluster analysis demonstrating that outbreaks involving BCoV, BRSV, and other viruses cluster in this age group during cold months, whereas older fattening calves exhibit a distinct epidemiological pattern with reduced viral involvement [13]. This age-dependent susceptibility likely reflects waning maternal antibody protection, immunological naivety, and the physiological stressors of weaning transition.

Coinfection dynamics represent a critical epidemiological dimension of BCoV respiratory disease. The virus rarely acts in isolation; rather, it operates within a complex microbial ecosystem. In Norwegian BRD outbreaks, BCoV frequently coexists with BRSV and bovine parainfluenza virus 3, though BRSV typically represents the predominant viral agent when present [54]. Sequential infection experiments have demonstrated that prior bovine viral diarrhea virus (BVDV) infection potentiates BCoV pathogenicity, with dual-infected calves developing significantly more pronounced lung lesions consistent with moderate interstitial pneumonia compared to those infected with BCoV alone [10]. The mechanistic basis for this synergism involves BVDV-induced immunosuppression, which facilitates BCoV replication and dissemination. At the cellular level, BCoV infection upregulates intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAF-R) on bovine respiratory epithelial cells, enhancing adherence of Pasteurella multocida and potentiating bacterial pneumonia development [23]. This virus-bacteria interface is epidemiologically critical: in Polish dairy herds, BCoV showed statistically significant correlations with Mannheimia haemolytica detection (odds ratio 2.8, 95% CI: 1.1–7.5), and a previous history of BCoV detection by antigen ELISA on feces was associated with a 3.6-fold increased risk of respiratory BCoV detection [39].

Immunological factors exert profound epidemiological influence. Seropositivity upon arrival at veal facilities conferred significant protection against lung consolidation, with BCoV-seropositive calves showing reduced odds of developing consolidation at peak BRD incidence (OR 0.37, 95% CI: 0.20–0.69) compared to seronegative counterparts [40]. However, the relationship between maternal antibody levels and protection is complex; longitudinal studies of 817 preweaned beef calves across three herds demonstrated that serum anti-BCoV antibody abundance did not consistently associate with BRD incidence or BCoV shedding, possibly due to the long intervals between sample collections obscuring dynamic immune responses [11]. Calves with failed transfer of passive immunity (serum IgG < 7.5 g/L) gained 40 g/day less weight over the first 10 weeks of fattening, emphasizing the epidemiological importance of colostrum management in modulating population-level susceptibility [40].

Phylogenetic Diversity and Global Dispersal Patterns

The molecular epidemiology of BCoV respiratory infections reveals a dynamic evolutionary landscape characterized by substantial genetic diversity, geographic clustering, and ongoing adaptive evolution. Phylodynamic analyses based on complete genome and spike protein sequences have demonstrated that BCoV exhibits high mutation and recombination rates, particularly affecting the spike glycoprotein, which undergoes significant positive selective pressure, especially episodic selection, localized primarily on the protein surface, strongly suggesting immune-driven antigenic evolution [37]. This genetic plasticity enables BCoV to evade host immune responses and potentially alter tissue tropism, complicating vaccine development and cross-protection strategies.

Geographic dispersal patterns of BCoV strongly mirror international cattle trade networks. Comprehensive phylogeographic analyses have identified two major global clusters: a European cluster characterized by relatively dense and rapid migration networks, and an American–Asian cluster dominated by the primary role of the United States as a viral exportation source [37]. Within the American–Asian cluster, BCoV strains from Brazil form a distinct clade that originated from dual enteric and respiratory tropism evolution. Brazilian BCoV strains clustered with recent winter dysentery-associated isolates rather than classical enteric prototypes, demonstrating 98–99% nucleotide identity with strains showing dual tropism, suggesting that Brazilian BCoV evolved from exclusively enteric ancestors to acquire respiratory pathogenicity [53]. The Brazilian genotype #15, identified through S1 gene phylogenetic analysis, forms a new branch ancestrally distinct from prototype vaccine strains and previously described Brazilian isolates, highlighting ongoing regional diversification [4].

Asian genotypic patterns reveal complex evolutionary trajectories. Japanese BCoV strains isolated after 2005 form an individual lineage distinct from strains found in other countries, suggesting unique regional evolution [27]. More recent surveys in Chiba Prefecture document coexistence of Japan G3 and G4 genotypes, refuting earlier hypotheses that G3 had disappeared from Japanese cattle populations [2]. Korean BCoV strains demonstrate temporal genotype shifting: strains isolated before 2000 belonged to group GI, while those isolated after 2000 belong to group GIIa, which now predominates in South Korean cattle [34]. Chinese BCoV strains predominantly belong to the GIIb genotype, which is epidemic across Asia and the Americas, with the recently isolated BCoV NXWZ2310 strain (GIIb) harboring a unique three-amino-acid deletion in the N gene serine-rich region that may confer enhanced pathogenicity and altered antigenicity [6, 22]. The striking sequence identity between the S gene of Inner Mongolian BCoV isolates and the QH1 strain (MH810151.1) isolated from yak suggests potential interspecies transmission events, indicating that BCoV may move between cattle and wild ruminant populations, with implications for disease persistence and emergence [22].

At the molecular level, the nucleocapsid (N) gene is relatively conserved, with BCoV strains from China and the United States showing high sequence identity, while the spike (S) gene exhibits substantial variability. The first linear B-cell epitope identified on the BCoV N protein (380YQQQDG385) demonstrates high conservation across nine typical BCoV strains from different geographic areas but remarkably low homology with other animal-derived betacoronaviruses, except for 100% identity with human coronavirus OC43 and canine respiratory coronavirus CRCoV/BJ-221 [20]. This epitope conservation provides a molecular target for diagnostic development while simultaneously illuminating the evolutionary relationships within the Betacoronavirus genus that may have implications for cross-species transmission and zoonotic risk assessment.

Diagnostic Challenges and Surveillance Implications for Global Epidemiology

Accurate estimation of BCoV respiratory infection prevalence is fundamentally constrained by diagnostic methodology, sample type, and timing of collection relative to infection dynamics. The relative performance of diagnostic assays dramatically influences reported epidemiological patterns. Bayesian latent class modeling comparing qPCR and nanopore metagenomic sequencing for BCoV detection in 760 nasal swabs from western Canadian feedlots revealed that qPCR exhibited higher diagnostic sensitivity (0.90, 95% CrI 0.81–0.99) compared to sequencing (0.35, 95% CrI 0.25–0.46), but sequencing demonstrated superior specificity (0.91 vs. 0.59) [48]. These findings suggest that qPCR-based surveillance may overestimate true prevalence due to cross-reactivity or detection of non-viable virus, while metagenomic approaches may underestimate prevalence due to lower analytical sensitivity. Emerging technologies such as CRISPR-Cas13a combined with reverse transcription recombinase-aided amplification (RT-RAA) offer alternative approaches, with detection limits of 1.72 copies/μL and the ability to detect BCoV in 58.3% of clinical samples compared to only 2.4% by RT-qPCR (p < 0.001), suggesting that many epidemiological surveys may substantially underestimate true BCoV circulation [49].

Sample selection further complicates epidemiological interpretation. Nasal swabs may not adequately reflect lower respiratory tract infection status; agreement between virus identification in nasal swabs and tracheal washes is generally weak, indicating that sampling location significantly affects detection probability [51]. Nasopharynx-associated lymphoid tissue (NALT) serves as a site of BCoV replication, with in situ hybridization detecting BCoV-positive signals in NALT epithelial cells, confirming that the upper respiratory tract is a critical compartment for viral replication and potential transmission [44]. However, bronchoalveolar lavage fluids and lung tissue samples provide more definitive evidence of lower respiratory involvement, with immunohistochemistry and RNAscope in situ hybridization confirming BCoV antigen in tracheal epithelium and alveolar debris, particularly in cases with tracheal epithelial attenuation [5]. These methodological considerations emphasize that single-timepoint, single-sample-type surveys may substantially misrepresent the true epidemiological burden of BCoV respiratory infections.

Serological surveillance provides complementary population-level data but carries its own interpretive challenges. The Norwegian control program’s use of bulk tank milk antibody testing, combined with Bayesian latent class analysis, revealed that the MVD-Enferplex BCoV/BRSV multiplex immunoassay achieves sensitivity of 99.9% and specificity of 93.7% at optimized cutoffs, while the SVANOVIR BCV-Ab ELISA demonstrates sensitivity of 99.5% and specificity of 99.6% [52]. These diagnostic characteristics have enabled herd-level classification for the Norwegian eradication program, which has demonstrated that test-negative herds can maintain freedom from BCoV through enhanced biosecurity measures, though the probability of freedom decreases with time since testing and is significantly affected by livestock purchases [45]. The success of this program in a high-prevalence endemic setting provides a template for population-based BCoV control that could be adapted to other regions, though it requires robust diagnostic infrastructure, stakeholder engagement, and sustained biosecurity investments [43].

Implications for Future Epidemiological Research and Control

The epidemiological evidence accumulated over the past decade conclusively establishes BCoV as a globally distributed, primary respiratory pathogen of cattle that contributes substantially to BRDC morbidity, mortality, and economic losses across all major cattle-producing regions. Prevalence estimates ranging from <1% to >60% across different studies reflect true geographic and management variation but also underscore the critical need for standardized diagnostic approaches and surveillance methodologies to enable meaningful cross-regional comparisons. The recognition that BCoV genotypes exhibit geographic clustering, ongoing evolutionary diversification, and potential for interspecies transmission necessitates continued molecular surveillance to monitor emergence of novel variants that may escape vaccine-induced immunity or exhibit altered tissue tropism. The demonstrated synergy between BCoV and other BRDC pathogens, both viral and bacterial, highlights the importance of comprehensive diagnostic panels in outbreak investigations and the potential for BCoV vaccination to reduce overall BRDC incidence through disruption of pathogen synergy cascades. The Norwegian control program’s success in reducing BCoV prevalence through voluntary biosecurity and antibody testing without vaccination provides evidence that population-level control is achievable, though it requires sustained commitment from producers, veterinarians, and regulatory authorities. Future epidemiological research must prioritize longitudinal cohort studies that capture the dynamic interplay between maternal antibody waning, natural infection, and vaccine-induced immunity, as well as investigations into the role of wildlife reservoirs and environmental persistence in maintaining BCoV transmission cycles.

Clinical and Pathological Features of Bovine Coronavirus Respiratory Disease

Bovine coronavirus (BCoV) has emerged as a critical pathogen within the bovine respiratory disease complex (BRDC), a multifactorial syndrome responsible for substantial morbidity, mortality, and economic losses in the global cattle industry. The World Organisation for Animal Health (WOAH) recognizes BRDC as a disease of major economic significance, and the Food and Agriculture Organization (FAO) has highlighted the need for improved surveillance and control strategies. Historically regarded primarily as an enteric pathogen causing neonatal calf diarrhea and winter dysentery in adult cattle, BCoV is now incontrovertibly established as a primary respiratory pathogen capable of inducing a spectrum of clinical manifestations ranging from subclinical infection to acute, fatal respiratory distress [5, 17, 24, 33]. The clinical and pathological features of BCoV respiratory disease are highly variable, influenced by viral strain, host age and immune status, environmental stressors, and the presence of concurrent infections, particularly with bacterial opportunistic pathogens [1, 10, 23, 39].

Clinical Manifestations

The clinical presentation of BCoV respiratory disease spans a continuum from mild upper respiratory tract disease (URTD) to severe interstitial pneumonia that can culminate in death. In young calves, particularly those under six months of age, clinical signs typically manifest as serous to mucopurulent nasal discharge, coughing, tachypnea, pyrexia (frequently exceeding 40°C), and a variable degree of depression and anorexia [3, 6, 17, 55]. Experimental intranasal challenge studies have demonstrated that clinical signs can appear as early as two to four days post-inoculation, with peak severity occurring between days four and eight [17, 31]. Fever is a consistent feature, and in one experimental study using the virulent BCoV OK 1776 isolate, significant pyrexia was observed in all virus-inoculated groups [10]. The course of disease in uncomplicated BCoV infections is often self-limiting, with clinical signs resolving within 7–14 days. However, in cases where BCoV acts in concert with other viral or bacterial pathogens, the disease can be rapidly progressive and fatal.

A critical observation is that BCoV can cause severe, even fatal, respiratory disease in the absence of other identifiable viral co-pathogens. A study of a BRDC outbreak in eastern Poland, where 11 newly introduced calves exhibited both respiratory and enteric signs, resulted in eight fatalities within two weeks. Diagnostic testing confirmed BCoV as the sole viral agent, with no detection of bovine viral diarrhea virus (BVDV), bovine herpesvirus 1 (BoHV-1), or bovine respiratory syncytial virus (BRSV) [3]. This finding underscores the primary pathogenicity of BCoV. Similarly, a dramatic outbreak in a high-production dairy herd in southern Italy described five adult cows that died with severe respiratory distress (coughing and gasping breath) within 3–4 days of clinical onset. Real-time PCR detected BCoV RNA in the lungs, small intestine, mediastinal lymph nodes, liver, and placenta, with no pathogenic bacteria isolated, leading the authors to describe a fatal interstitial pneumonia syndrome reminiscent of severe acute respiratory syndromes (SARS) in humans [38, 42]. This demonstrates that BCoV is not limited to mild disease in young animals but can induce fulminant respiratory failure in adult cattle.

The severity of clinical disease is potentiated by environmental and management-related stressors. Transport, weaning, commingling, and adverse weather conditions are well-established triggers for BRD outbreaks. A longitudinal study of 817 pre-weaned beef calves found that 30.4% were treated for BRD, and BCoV was frequently co-detected with Histophilus somni at the time of disease outbreak [11]. In a cross-sectional study of beef steers transported from France to Italy, the number of animals shedding BCoV increased dramatically from 16.0% at loading to 82.8% four days after arrival, and co-infection rates surged, demonstrating the profound impact of transport stress on viral shedding and clinical disease development [16]. Similarly, studies on feedlot cattle consistently identify BCoV as one of the most prevalent viruses in nasal swabs upon arrival, with detection rates as high as 45.2% in western Canadian feedlots [25]. This high prevalence at the point of entry into high-risk environments, combined with the stress of transport and commingling, positions BCoV as a key initiating agent in the classic feedlot BRD cascade.

Clinical signs are often exacerbated by concurrent bacterial infections. BCoV infection of the respiratory epithelium damages the mucociliary apparatus and disrupts epithelial barrier integrity, creating a permissive environment for secondary bacterial invasion. In a study of Indian calves, cases with dual BCoV and Pasteurella multocida infection presented with a more severe clinical picture, characterized by marked dyspnea and a higher mortality rate, compared to those with BCoV infection alone [1]. Furthermore, it is now understood that BCoV also enhances bacterial adherence at a molecular level. Infection of bovine respiratory epithelial cells with BCoV upregulates the expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAF-R), two major cellular receptors that facilitate the adherence of P. multocida. This specific molecular mechanism explains, in part, the frequent and severe synergism observed between BCoV and bacterial pathogens in field outbreaks [23].

Subclinical and Asymptomatic Infections

A major challenge in controlling BCoV respiratory disease is the high prevalence of subclinical or asymptomatic shedding. Numerous studies have detected BCoV in nasal swabs of healthy calves without any overt clinical signs, indicating widespread viral circulation within herds. A study in Japan found that while 21.2% of cattle with respiratory disease were positive for BCoV, the virus was also detectable in asymptomatic animals, though at significantly lower viral loads (4.7 times lower) [27]. Similarly, a Brazilian study of high-production dairy herds reported a BCoV detection rate of 56% in nasal swabs, with the virus being present in both symptomatic and asymptomatic heifer calves [4]. These findings suggest that a large proportion of infected animals act as silent shedders, perpetuating the transmission cycle and making eradication efforts extremely difficult. The detection of BCoV in the nasopharynx-associated lymphoid tissue (NALT) of both healthy and pneumonic calves further supports the concept of a persistent viral reservoir in the upper respiratory tract [44]. This subclinical shedding is a critical feature of BCoV epidemiology and contributes to the failure of many control programs based solely on clinical surveillance.

Gross Pathological Findings

The macroscopic pulmonary lesions associated with BCoV respiratory disease, while not pathognomonic, follow a distinct pattern that reflects the pathogenesis of the virus. The hallmark lesion is a cranioventral consolidation, often affecting the right middle, cranial, and accessory lung lobes. These areas of consolidation are typically dark red to purple, firm, and fail to collapse upon opening the thoracic cavity [1, 6]. The affected tissue is often depressed below the level of the surrounding normal lung and, upon sectioning, may exude a moderate amount of serosanguinous or mucopurulent fluid depending on the presence of secondary bacterial infection.

In BCoV cases with minimal or no bacterial co-infection, the caudodorsal lobes of the lung are often described as non-collapsed, overly inflated, and pale, suggestive of compensatory emphysema [1]. This pattern of cranioventral consolidation with concurrent caudodorsal emphysema is a classic gross description of viral interstitial pneumonia in calves. This can be distinguished from severe bacterial bronchopneumonia, where the consolidation is often more extensive, has a more intense purulent exudate, and may involve entire lobes with abscess formation. In experimental infections, the gross lesions are often reported as mild to moderate. In one study, intranasal challenge with BCoV resulted in variable pulmonary consolidation, but the lesions were more pronounced in animals that underwent sequential infection with BVDV followed by BCoV, confirming the synergistic effect of dual viral infection on gross pathology [10]. In a study of an emerging GIIb genotype strain (NXWZ2310) with a three-amino-acid deletion in the N gene, significant parenchymal lesions of the pulmonary lobes were documented, highlighting that genetic variation in circulating strains can influence the severity of gross pathology [6].

Histopathological Features

The microscopic pathology of BCoV respiratory disease is characterized by a spectrum of changes that reflect the virus's ability to infect and damage the respiratory epithelium. The most consistent finding is an interstitial pneumonia, which is the hallmark of primary viral damage to the alveolar and bronchiolar structures. This is characterized by a moderate to severe thickening of the interalveolar septa due to the infiltration of mononuclear inflammatory cells, predominantly lymphocytes and macrophages, along with an increase in the number of fibroblasts [1, 5, 17]. The alveolar lumina are often found to contain a mixture of proteinaceous fluid, cellular debris, and sloughed epithelial cells.

In addition to the interstitial changes, there is often evidence of significant damage to the bronchiolar and bronchial epithelium. This includes epithelial attenuation, where the normally columnar epithelial cells become flattened and low cuboidal, and necrosis with sloughing of epithelial cells into the airway lumen [5, 17]. The airway lumina themselves may contain a mixture of necrotic cellular debris, mucus, and inflammatory cells, leading to partial or complete obstruction.

The nature of the inflammatory exudate is a critical discriminator between viral and bacterial pathology. In cases of BCoV infection alone, the cellular infiltrate is predominantly mononuclear (lymphocytic), and neutrophils are scarce. However, in cases where BCoV is accompanied by a bacterial co-infection, the pathological picture shifts dramatically. For instance, in calves with concurrent P. multocida infection, the cranioventral lung lobes exhibit a classic suppurative bronchopneumonia, characterized by a dense neutrophilic exudate filling the bronchi, bronchioles, and alveoli [1]. This distinction is critical for pathologists and diagnosticians, as the presence of a suppurative component strongly suggests secondary bacterial invasion and dramatically alters the therapeutic approach, such as the need for aggressive antimicrobial therapy.

Detection of Viral Antigen and RNA within Lesions

The definitive confirmation of BCoV as the etiological agent responsible for the observed pulmonary lesions relies on the direct detection of the virus within the affected tissues. Immunohistochemistry (IHC) has been successfully employed to demonstrate BCoV antigen in the cytoplasm of epithelial cells lining the bronchi, bronchioles, and alveoli [1, 5, 10]. Moreover, viral antigen is also frequently detected within the cellular debris present in the airway lumens, confirming that these cells were productively infected [1].

More recently, RNA in situ hybridization (ISH) using RNAscope technology has proven to be a superior method for detecting BCoV in respiratory tissues. A landmark study comparing IHC and ISH in lung tissues from 104 calves with BRD found that RNAscope detected BCoV RNA in respiratory epithelium in a greater number of cases than IHC [5]. This enhanced sensitivity is likely due to the probe-based signal amplification system, which can detect low-copy-number viral RNA even when protein levels are below the threshold for IHC detection. Importantly, this study also demonstrated that viral RNA was commonly identified within areas of tracheal epithelial attenuation, providing direct evidence of BCoV's role in causing respiratory tract pathology [5].

The distribution of viral antigen and RNA confirms the broad tissue tropism of BCoV. BCoV is not limited to the lungs; it consistently infects the epithelial cells of the nasopharynx, trachea, and bronchi. Furthermore, a comprehensive experimental intranasal inoculation study by Cho et al. (2026) demonstrated that BCoV exhibits a broad tissue tropism beyond the classical respiratory tract. Using digital RT-PCR and IHC, the virus was detected in the tonsil, trachea, lung, liver, kidney, abomasum, and both small and large intestines. This indicates that BCoV initiates replication in the respiratory epithelium and subsequently disseminates to the digestive tract, unifying the respiratory and enteric syndromes [31]. This finding is critical, as it suggests that even in cases presenting primarily with respiratory signs, the virus may be actively replicating in the gastrointestinal tract, contributing to subclinical enteric damage and potential shedding. The NALT is also a significant site of viral replication, as demonstrated by ISH showing BCoV-positive signals in NALT epithelial cells, indicating that this mucosal immune tissue may serve as a primary replication niche and a gateway for systemic dissemination [44].

Molecular Pathogenesis: Mechanisms of Tissue Damage

The pathological features of BCoV respiratory disease are a direct consequence of the virus's interaction with host cellular machinery at the molecular level. The virus infects and destroys ciliated epithelial cells in the upper and lower respiratory tract. This destruction impairs the mucociliary elevator, the primary physical defense mechanism for clearing inhaled pathogens and debris, thereby predisposing the animal to secondary bacterial colonization and aspiration pneumonia.

At the cellular level, BCoV infection triggers a cascade of events that contribute to tissue damage. Proteomic and transcriptomic analyses of BCoV-infected Madin Darby Bovine Kidney (MDBK) cells reveal that the virus profoundly alters host cell metabolism, endocytosis, and apoptosis pathways. Critically, BCoV suppresses the complement and coagulation cascades by downregulating complement component C3, which may impair the host's ability to opsonize and clear the virus and bacteria [18]. Furthermore, BCoV non-structural protein 14 (nsp14) actively degrades TNF receptor-associated factor 3 (TRAF3) by hijacking the host's ubiquitin-proteasome and autophagy-lysosomal pathways. This degradation of TRAF3 effectively blocks the activation of interferon regulatory factor 3 (IRF3) and subsequent production of type I interferon (IFN-β), a key antiviral cytokine. By suppressing the innate antiviral response, BCoV establishes a state of local immunosuppression that facilitates viral replication and potentiates the outgrowth of secondary bacterial pathogens [19].

The interaction between BCoV infection and the immune system is further evident in the pathology seen in dual infections. Sequential infection with BVDV followed by BCoV produces the most severe lung lesions, characterized by a more intense and widespread interstitial pneumonia [10]. BVDV is known to be immunosuppressive, further tipping the balance in favor of BCoV replication and tissue damage. This model of sequential viral infection highlights the complex interplay within the BRDC, where the timing of infection is as critical as the identity of the pathogens involved.

In summary, the clinical and pathological features of BCoV respiratory disease are a dynamic reflection of viral virulence, host susceptibility, and environmental context. The virus acts as both a primary pathogen, capable of inducing fatal interstitial pneumonia in its own right, and as an initiator of the classic BRD cascade, where damage to the respiratory epithelium and suppression of local immunity creates a niche for opportunistic bacterial pathogens. The detection of BCoV within characteristic lesions, coupled with an understanding of its molecular mechanisms of immune evasion, solidifies its status as a cornerstone of the bovine respiratory disease complex.

Diagnostic Methods for Bovine Coronavirus Respiratory Disease

The accurate diagnosis of bovine coronavirus (BCoV) as a causative agent within the bovine respiratory disease complex (BRDC) presents a unique set of challenges and opportunities. Unlike the straightforward detection of an enteric pathogen in diarrheic feces, confirming the role of BCoV in respiratory pathology requires a multifaceted approach that integrates molecular, serological, virological, and histopathological evidence. The diagnostic journey must navigate the complex etiology of BRDC, where BCoV frequently co-infects with bacterial pathogens such as Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni, as well as other viruses like bovine respiratory syncytial virus (BRSV) and bovine viral diarrhea virus (BVDV) [4, 11, 13, 15]. This section provides a comprehensive analysis of the diagnostic methods available for BCoV respiratory disease, from traditional techniques to cutting-edge genomic and point-of-care technologies, with a focus on their biological principles, diagnostic performance, and practical application in clinical and research settings. The World Organisation for Animal Health (WOAH) recognizes the importance of robust diagnostic capabilities for monitoring and controlling BCoV, and these methods form the cornerstone of effective surveillance and intervention strategies.

The Foundational Role of Virus Isolation and Antigen Detection

Historically, the gold standard for confirming an active viral infection has been virus isolation (VI) in cell culture. For BCoV, this typically involves inoculating samples (nasal swabs, lung tissue homogenates, bronchoalveolar lavage fluid) onto susceptible cell lines, most commonly Madin-Darby Bovine Kidney (MDBK) cells or primary calf kidney (CK) cells [37, 59]. Successful isolation is characterized by the observation of a characteristic cytopathic effect (CPE), which for BCoV often manifests as syncytia formation, the fusion of adjacent cells into multinucleated giant cells [37, 59]. Source [59] demonstrated that while 16 out of 20 samples from calves with respiratory or gastrointestinal signs were positive by real-time PCR, only four of these isolates produced a typical syncytial CPE by the fifth passage, highlighting a significant limitation: VI can be insensitive, time-consuming (often requiring multiple blind passages), and technically demanding. The failure to isolate virus from PCR-positive samples may be due to the presence of non-viable virus, low viral titers, or the existence of fastidious strains that do not adapt readily to in vitro culture [59]. Despite these drawbacks, VI remains essential for obtaining live virus for subsequent characterization, vaccine development, and detailed pathogenesis studies.

Complementary to VI is the direct detection of viral antigen in tissues. Immunohistochemistry (IHC) is a powerful technique that allows for the spatial localization of BCoV antigen within formalin-fixed, paraffin-embedded tissue sections, providing a direct link between the presence of the virus and histological lesions. Several studies have leveraged IHC to confirm BCoV involvement in respiratory disease. Source [1] used IHC to colocalize BCoV antigen with lesions of interstitial pneumonia in the lungs of calves, demonstrating viral antigen in epithelial cells and within debris in the lumens of alveoli and bronchi/bronchioles. Similarly, source [5] employed IHC alongside an RNA in situ hybridization (ISH) assay (RNAscope). While both methods were effective, the ISH assay proved to be more sensitive, detecting BCoV in respiratory epithelium in a greater number of cases than IHC. This is likely because ISH directly detects viral RNA, which can be present in high copy numbers even when viral protein expression is low or masked by host immune responses. The study by [5] confirmed that tracheal epithelial attenuation and virus identification within lesions were common, providing critical evidence that BCoV replicates in and damages the respiratory tract. The use of IHC and ISH is therefore invaluable for definitive diagnosis, especially when trying to differentiate primary viral pneumonia from secondary bacterial infection. Source [10] used IHC to confirm the presence of BoCV antigen in lung lesions of calves co-infected with BVDV and BoCV, demonstrating the utility of this method in complex mixed-infection scenarios.

Molecular Diagnostics: The Cornerstone of Modern Detection

Nucleic acid amplification tests (NAATs), particularly reverse transcription polymerase chain reaction (RT-PCR) and its real-time quantitative variant (RT-qPCR), have become the workhorses for BCoV diagnosis due to their exceptional sensitivity, specificity, and speed. These assays target conserved regions of the BCoV genome, most often the nucleocapsid (N) gene and the RNA-dependent RNA polymerase (RdRp) gene, though the spike (S) gene is also targeted for genotyping purposes [1, 7, 9, 27].

Qualitative and Quantitative RT-PCR

Conventional RT-PCR, such as the assay targeting a 172-base pair fragment of the N gene used by Kamdi et al. [1], provides a qualitative yes/no answer regarding the presence of viral RNA. This method is highly sensitive and was instrumental in confirming BCoV in a low-prevalence setting in India, where only 0.98% of BRDC cases were positive [1]. The power of this approach lies in its ability to detect even low levels of viral RNA, which is critical for identifying subclinical shedders or early-stage infections before clinical signs are pronounced.

Real-time RT-PCR (RT-qPCR) offers the added advantage of quantification, providing a cycle threshold (Ct) value that is inversely proportional to the viral load in the sample. This quantitative capability has profound implications for understanding pathogenesis and transmission dynamics. Sekine et al. [2] used RT-qPCR to identify a 43.8% BCoV RNA positivity rate in nasal swabs from cattle with respiratory symptoms in Japan, and then used the detected RNA for subsequent virus isolation and phylogenetic analysis. Mekata et al. [27] reported that respiratory-diseased cattle had viral loads 4.7 times higher than those in asymptomatic cattle, a finding that directly links high-level viral replication to clinical disease. The quantitative nature of RT-qPCR also makes it ideal for monitoring viral shedding kinetics. Source [6] used RT-qPCR to quantify BCoV shedding in nasal, throat, and rectal swabs of experimentally infected calves, revealing peak titers as high as 10⁶.⁶⁹² copies/mL in rectal swabs.

The diagnostic sensitivity of RT-qPCR is generally very high. A Bayesian latent class model analysis by Donbraye et al. [48] estimated the diagnostic sensitivity of qPCR for BCoV at 0.90 (95% CrI 0.81–0.99), outperforming nanopore metagenomic sequencing (0.35). However, the same study revealed a critical and often overlooked weakness: the specificity of qPCR was estimated at only 0.59 (95% CrI 0.51–0.68) for BCoV [48]. This suggests a high rate of false-positive results, potentially due to the detection of non-viable virus or transient, clinically irrelevant infections. This finding underscores a major challenge in BRDC diagnosis: a positive PCR result does not always equate to clinical significance. The mere presence of BCoV RNA in the upper respiratory tract of a healthy animal does not confirm its role in a concurrent pneumonia [4, 25]. Therefore, RT-qPCR results must always be interpreted in conjunction with clinical signs, histopathology, and ideally, quantitative viral load data.

Multiplex PCR Systems for BRDC

Given the polymicrobial nature of BRDC, diagnostic approaches that can simultaneously detect a panel of pathogens are highly advantageous. Several multiplex real-time PCR assays have been developed and validated for this purpose. Hao et al. [56] developed a novel multiplex qPCR assay capable of detecting eight major BRDC-associated pathogens, including BCoV, BVDV, BPIV-3, BRSV, Mycoplasma bovis, P. multocida, M. haemolytica, and IBRV. The assay demonstrated high specificity (no cross-reactivity), a limit of detection (LOD) as low as 5 copies per reaction, and excellent reproducibility (CVs < 2%). Clinical validation on 1,012 field samples revealed a BCoV-positive rate of 26.79% on one farm and 2.36% on another, highlighting the variability of infection between populations [56]. Another robust system, the "Dembo respiratory-PCR," targets 16 bovine respiratory pathogens in a single run, providing a comprehensive screening tool [57]. Such multiplex systems are invaluable for epidemiological surveys, outbreak investigations, and guiding therapeutic decisions (e.g., the need for antibacterial vs. antiviral therapy). Source [39] used a semi-quantitative PCR on bronchoalveolar lavage samples from 128 BRD outbreaks, identifying BCoV as the most frequently detected virus (38.4%), demonstrating the power of this approach for large-scale field studies.

Alternative and Point-of-Care Molecular Techniques

The need for rapid, field-deployable diagnostics that do not rely on expensive thermal cyclers has spurred the development of isothermal amplification methods. One of the most promising is the combination of reverse transcription recombinase-aided amplification (RT-RAA) with CRISPR-Cas13a technology. Liang et al. [49] established an RT-RAA-CRISPR/Cas13a assay targeting the conserved N gene of BCoV. This assay achieved a remarkable detection limit of 1.72 copies/μL, with no cross-reactivity against ten other common bovine pathogens. Importantly, when tested on 84 clinical samples, this novel method detected a BCoV positive rate of 58.3%, which was significantly higher than the 2.4% detected by a commercial RT-qPCR kit (p < 0.001). All 49 positive results were confirmed by Sanger sequencing, indicating that the CRISPR-based assay may be more sensitive than current gold-standard qPCR, possibly due to less stringent nucleic acid extraction requirements or a different target recognition mechanism. This technology holds immense potential for on-farm diagnosis, enabling rapid detection and intervention during outbreaks.

Serological Diagnosis: Antibody Detection for Surveillance and Research

While molecular assays detect current or recent infection, serological tests detect past exposure or the host's immune response. These tools are critical for population-level surveillance, herd health monitoring, and vaccine efficacy studies.

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISAs are the most common serological method used in routine diagnostics and large-scale surveys. They are relatively inexpensive, easy to standardize, and can be applied to serum, plasma, and bulk tank milk (BTM) samples. Commercial indirect ELISAs are widely available and have been used to determine herd-level prevalence. Wolff et al. [35] used commercial indirect ELISAs to compare BCoV seroprevalence in Swedish organic and conventional dairy herds, finding high overall herd-level prevalence (76.8% to 85.3%). The Norwegian national control program for BRSV and BCoV is a landmark example of using serology for disease management [43, 45]. The program classifies herds based on antibody testing of BTM using a multiplex immunoassay, and then implements biosecurity measures to prevent virus introduction [43]. This approach demonstrated that test-negative herds could maintain a high probability of freedom from infection over time, though the probability decreased with animal purchases and time elapsed since testing [45].

The performance of ELISA tests is crucial. Toftaker et al. [52] used Bayesian latent class analysis to evaluate a multiplex immunoassay against a commercial ELISA for detecting BCoV antibodies in BTM. At the recommended cut-off, the multiplex assay showed a sensitivity of 99.9% and specificity of 93.7%, while the commercial ELISA showed a sensitivity of 99.5% and specificity of 99.6% [52]. This high specificity is desirable to avoid false-positive herd classifications that could lead to unnecessary and costly control measures. The choice of test and cut-off can be optimized based on the purpose (e.g., surveillance vs. confirming infection). Source [39] further demonstrated the relevance of antigen ELISA on feces as a risk factor for BCoV detection in respiratory outbreaks, linking enteric and respiratory infections.

Virus Neutralization (VN) and Hemagglutination Inhibition (HI) Tests

The virus neutralization (VN) test is considered the gold standard serological assay because it specifically measures functional antibodies capable of blocking viral infectivity. However, it is labor-intensive, requires live virus and cell culture, and is not suitable for high-throughput screening. It remains essential for research, vaccine evaluation, and confirming ambiguous ELISA results. The hemagglutination inhibition (HI) test is another classical method that leverages the hemagglutinating properties of BCoV. While traditionally used for other viruses, its application for BCoV is less common, but a study by Hyeon et al. [58] demonstrated a strong correlation (R = 0.83) between the HI test and VN test for canine respiratory coronavirus (CRCoV), a virus closely related to BCoV. This suggests that the HI test could be a useful surrogate for VN in certain contexts. Source [55] used serological responses to evaluate the efficacy of a live-attenuated BCoV vaccine, demonstrating that vaccinated calves had significantly lower virus loads in nasal and rectal swabs post-challenge, a finding underpinned by serological monitoring.

Advanced Molecular Characterization: Sequencing and Metagenomics

Beyond mere detection, determining the genetic identity and relatedness of BCoV strains is critical for understanding viral evolution, transmission patterns, and the emergence of novel variants.

Genome Sequencing and Phylogenetic Analysis

The complete or partial sequencing of BCoV genes, especially the spike (S) and nucleocapsid (N) genes, is a powerful tool for molecular epidemiology. Phylogenetic analysis allows researchers to classify strains into genotypes (e.g., GIIa, GIIb, GI) and trace their geographic spread. Sekine et al. [2] used sequencing of the S gene's polymorphic region to classify Japanese BCoV strains into G3 and G4 genotypes, demonstrating their coexistence in Chiba Prefecture. Frucchi et al. [4] sequenced the S1 gene of Brazilian BCoV strains and identified a new genotype (#15), indicating that the circulating field strains are ancestrally different from prototype vaccine strains. In another example, Li et al. [6] sequenced the complete genome of a novel Chinese strain (NXWZ2310) belonging to the GIIb genotype, which possessed a unique three-amino-acid deletion in the N gene and was associated with severe respiratory disease. Such detailed genomic characterization is crucial for assessing the relevance of vaccine strains and tracking the emergence of potentially more virulent or antigenically distinct viruses. Source [7] reported 24 near-complete BCoV genome sequences directly from nasal swabs of Irish calves, highlighting the power of metagenomic approaches for capturing the genetic diversity of circulating strains without the need for virus isolation.

Metagenomic Sequencing for Unbiased Pathogen Discovery

Metagenomic next-generation sequencing (NGS) provides an unbiased view of the complete microbial community (the "infectome") in a clinical sample. Unlike targeted PCR, it can detect any pathogen without prior knowledge of its presence. Source [48] compared nanopore metagenomic sequencing to qPCR for detecting BRD viruses. While qPCR was more sensitive for BCoV detection (0.90 vs. 0.35), metagenomic sequencing showed superior specificity (0.91 vs. 0.59), suggesting it is less prone to false positives [48]. This "specific but less sensitive" profile makes metagenomics a powerful complementary tool.

Furthermore, metagenomics has led to the discovery of

Coinfections and the Role of Bovine Coronavirus in Bovine Respiratory Disease Complex

The position of Bovine Coronavirus (BCoV) within the etiological framework of the Bovine Respiratory Disease Complex (BRDC) has undergone a paradigm shift in recent years. Once relegated to the status of an incidental finding or a pathogen primarily of enteric significance, BCoV is now recognized as a central, and often primary, viral instigator within the complex polymicrobial interactions that define BRDC. The disease complex itself is not a simple infection but a dynamic, multifactorial syndrome where the interplay between viral and bacterial pathogens, host immunity, and environmental stressors dictates clinical outcome. BCoV’s role is particularly nuanced, as it frequently acts as a viral gatekeeper, disrupting mucosal barriers and modulating the host immune response in ways that facilitate secondary bacterial invasion and exacerbate disease severity. This section provides an exhaustive analysis of the coinfections involving BCoV, the mechanistic basis for these interactions, and the epidemiological patterns that underscore its critical importance in BRDC pathogenesis.

The Landscape of Coinfection: Prevalence and Patterns

The sheer frequency with which BCoV is detected alongside other respiratory pathogens underscores its integral role in BRDC. Epidemiological surveys consistently reveal that BCoV is rarely a solitary agent in clinical disease. A comprehensive study of 296 calves from 74 dairy herds in southwestern Poland found that while Pasteurella multocida was the most prevalent pathogen (87.84% herd-level), BCoV was detected in 32.43% of herds, and coinfections were the rule rather than the exception [15]. Critically, this study noted that no purely viral coinfections were detected; BCoV was almost invariably found in concert with bacterial species, most frequently P. multocida and Mannheimia haemolytica [15]. This pattern is echoed globally. In high-production dairy herds in Brazil, BCoV was the most frequently diagnosed viral agent (56% of nasal swabs), surpassing even P. multocida (39.8%) and M. haemolytica (33.1%), with the majority of BCoV-positive calves also harboring these bacterial pathogens [4]. Similarly, a longitudinal study of pre-weaned beef calves in the United States found that clinical BRD outbreaks were characterized by the co-detection of BCoV and Histophilus somni, suggesting a synergistic relationship that drives disease pathogenesis [11].

The complexity of these interactions is further illuminated by cluster analysis of BRD outbreaks. A study classifying 156 outbreaks based on pathogen detection identified two distinct epidemiological patterns. Cluster 1, characterized by a high frequency of viral pathogens including BCoV (40-72%), was strongly associated with pre-weaning calves under five months of age and cold-weather months [13]. This cluster represents the classic model of primary viral infection predisposing to secondary bacterial pneumonia. In contrast, Cluster 2, which affected older fattening calves, showed a lower frequency of viral involvement, suggesting that in some contexts, bacterial pathogens can act as primary agents [13]. This dichotomy highlights that BCoV’s role is context-dependent, but its presence in the high-viral cluster solidifies its status as a key primary pathogen in the most common epidemiological presentation of BRDC.

Mechanistic Basis for Viral-Bacterial Synergy

The transition from a subclinical BCoV infection to fulminant BRDC is not merely a matter of pathogen co-occurrence; it is a biologically driven process of viral-bacterial synergy. BCoV infection of the respiratory epithelium initiates a cascade of events that profoundly alters the local microenvironment, rendering the host exquisitely susceptible to secondary bacterial colonization and invasion.

Upregulation of Bacterial Adhesion Receptors: One of the most well-characterized mechanisms is the BCoV-mediated enhancement of bacterial adherence. Elegant in vitro studies using bovine epithelial cells from the trachea, bronchus, and lung have demonstrated that BCoV infection significantly increases the adherence of Pasteurella multocida [23]. This effect is mediated through the specific upregulation of two key cellular adhesion molecules: intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAF-R) [23]. These molecules serve as docking sites for bacterial adhesins, effectively turning the respiratory epithelium into a more permissive surface for bacterial attachment. This mechanism is distinct from that of other respiratory viruses like Bovine Respiratory Syncytial Virus (BRSV), which modulates bacterial adherence in a site-specific manner (increasing it in the lower tract but decreasing it in the upper tract). BCoV, in contrast, uniformly enhances adherence across both upper and lower respiratory epithelia, suggesting a particularly potent and broad mechanism for promoting bacterial superinfection [23].

Epithelial Damage and Barrier Disruption: Direct viral cytopathology is another critical component of synergy. BCoV infection causes necrosis and sloughing of respiratory epithelial cells, as confirmed by histopathology and direct viral detection via immunohistochemistry (IHC) and RNA in situ hybridization (ISH) [5]. This physical disruption of the mucosal barrier exposes the underlying basement membrane and connective tissue, providing direct access for opportunistic bacteria. The resulting tracheal epithelial attenuation and loss of ciliary function compromise the mucociliary escalator, a primary innate defense mechanism for clearing pathogens from the lower airways [5]. This breach of the physical barrier, combined with the loss of mechanical clearance, creates a permissive environment for bacterial proliferation and invasion into the lung parenchyma.

Immune Modulation and Viral Interference: Beyond physical damage, BCoV possesses sophisticated mechanisms to subvert the host immune response, further tipping the balance in favor of bacterial pathogens. The virus can directly suppress innate antiviral immunity. Research has shown that the BCoV non-structural protein 14 (nsp14) promotes viral replication by degrading TNF receptor-associated factor 3 (TRAF3), a key adaptor protein in the signaling cascade leading to interferon-β (IFN-β) production [19]. By inhibiting IFN-β production, BCoV dampens the host’s antiviral state, potentially allowing for more robust viral replication and creating a window of opportunity for secondary bacterial invaders. Furthermore, infection of the nasopharynx-associated lymphoid tissue (NALT) by BCoV can cause local immunosuppression. Detection of BCoV antigen in NALT epithelial cells, coupled with evidence of BVDV replication in NALT follicular macrophages, suggests that viral infections at this critical inductive site can impair local adaptive immune responses, facilitating the translocation of bacteria from the nasopharynx to the lungs [44].

Sequential Viral Infections and Disease Potentiation

The complexity of BRDC is further compounded by the potential for sequential infections with multiple viruses. The interaction between BCoV and Bovine Viral Diarrhea Virus (BVDV) provides a compelling example of how the order and timing of viral exposures can dramatically influence disease outcome. Experimental challenge studies have demonstrated that dual infection with BVDV followed by BCoV six days later results in significantly more severe lung lesions compared to infection with either virus alone [10]. The lung pathology in these dual-infected calves was consistent with moderate-to-severe interstitial pneumonia, and BCoV antigen was readily detected within the lesions [10]. This potentiation is likely due to the well-known immunosuppressive effects of BVDV, which can induce leukopenia and impair neutrophil and macrophage function. By pre-conditioning the host with an immunocompromised state, BVDV creates a permissive environment for BCoV to replicate to higher titers and cause more extensive tissue damage. This finding has profound implications for BRDC control, suggesting that vaccination strategies targeting BVDV may have a synergistic benefit in reducing the severity of BCoV-associated respiratory disease.

The Role of the Microbiome and Emerging Pathogens

The traditional view of BRDC as a simple interaction between a few canonical pathogens is giving way to a more holistic understanding that includes the entire respiratory microbiome. Metagenomic and metatranscriptomic studies have revealed a far more complex viral landscape, often termed the “respiratory infectome.” In feedlot cattle, BCoV is frequently detected alongside other viruses such as Influenza D virus (IDV), bovine rhinitis viruses, and bovine nidoviruses [32, 46, 51]. The clinical significance of these co-detections is an area of active investigation乐. For instance, IDV has been shown to cause mild to moderate respiratory disease and can potentiate the effects of other pathogens, including M. haemolytica [60]. The presence of BCoV in a mixed viral infection may therefore act as an additional stressor, compounding the immunosuppressive or barrier-disrupting effects of other viruses.

The bacterial component of the microbiome is equally dynamic. The upper respiratory tract of healthy calves harbors a complex community of commensal bacteria. However, stress and viral infection can disrupt this equilibrium, leading to dysbiosis and the overgrowth of opportunistic pathogens. A study of nursing beef calves found that a BRD outbreak was associated with a significant decrease in bacterial alpha diversity in the nasal microbiome and a concurrent increase in the abundance of Mycoplasma bovirhinis alongside BCoV [8]. This suggests that BCoV infection may not only facilitate invasion by classic pathogens like P. multocida but also create conditions favorable for the proliferation of other opportunistic bacteria that are normally present at low levels. The co-occurrence of BCoV with Mycoplasma bovis is also a frequent and clinically relevant finding, as M. bovis is associated with chronic, treatment-resistant pneumonia and arthritis [15, 39].

Epidemiological Context and Risk Factors

The role of BCoV in BRDC is inextricably linked to management and environmental risk factors that facilitate viral transmission and host stress. The virus is highly endemic in cattle populations worldwide, with seroprevalence rates often exceeding 80% in many regions [35, 37]. The introduction of BCoV into a naïve or susceptible population, particularly through the commingling of animals from different sources, is a major trigger for BRD outbreaks. This is starkly illustrated in the context of animal transport. A cross-sectional study of beef steers shipped from France to Italy found that the prevalence of BCoV detection increased dramatically from 16% at loading to over 80% four days after arrival, and this was accompanied by a massive increase in co-infections with bacteria like M. haemolytica and P. multocida [16]. The stress of transport, including weaning, handling, dehydration, and novel environmental exposure, is a potent immunosuppressant that synergizes with BCoV infection to precipitate clinical disease.

The Norwegian control program for BRSV and BCoV provides a real-world example of how understanding the epidemiology of these viruses can lead to effective population-level interventions. This voluntary program is based on classifying herds through antibody testing and then preventing virus introduction through strict biosecurity measures, including controlling animal movements and limiting indirect transmission [43, 45]. The success of this program, which operates without vaccination, underscores that BCoV transmission is driven by management practices and that reducing the force of infection can have a profound impact on BRD incidence. The World Organisation for Animal Health (WOAH) recognizes the significant economic impact of BRD, and programs like Norway’s serve as a model for sustainable disease control that reduces reliance on antimicrobials, a key goal in combating global antimicrobial resistance.

In conclusion, BCoV is not merely a passenger in the BRDC but a primary driver of pathogenesis. Its ability to upregulate bacterial receptors, disrupt epithelial barriers, and subvert immune responses creates a perfect storm for secondary bacterial pneumonia. The high frequency of co-detection with P. multocida, M. haemolytica, and H. somni, coupled with the potential for sequential viral infections to potentiate disease, firmly establishes BCoV as a critical target for intervention. Effective control of BRDC must therefore include strategies to mitigate BCoV infection, whether through vaccination, improved biosecurity, or management practices that reduce stress and limit viral transmission.

Molecular Characterization and Phylogenetic Diversity of Bovine Coronavirus Strains

The molecular architecture of bovine coronavirus (BCoV) is a testament to the profound evolutionary plasticity inherent within the Betacoronavirus genus, a family of pathogens that continues to challenge both veterinary and public health infrastructures globally. As a member of the species Betacoronavirus 1, BCoV possesses the largest known RNA genome among coronaviruses, approximately 31–32 kilobases in length, encoding a canonical array of structural proteins, the spike (S), hemagglutinin-esterase (HE), membrane (M), envelope (E), and nucleocapsid (N) proteins, alongside 16 non-structural proteins (nsps) that orchestrate RNA replication, transcription, and host immune evasion [33, 37]. The World Organisation for Animal Health (WOAH) recognizes BCoV as a pathogen of significant economic consequence, and the genetic heterogeneity observed among circulating strains underscores the necessity for continuous molecular surveillance to inform both diagnostic accuracy and vaccine efficacy.

The spike glycoprotein, a type I transmembrane protein mediating host cell attachment and fusion, represents the primary determinant of antigenic variation and tissue tropism. The S gene, particularly its 5′ terminus encompassing the S1 subunit, harbors a hypervariable region (HVR) that is subject to intense selective pressure, likely driven by immune recognition and host adaptation [37]. Phylogenetic analyses based on complete S gene sequences have consistently resolved BCoV strains into two major clades, provisionally designated GI and GII, with further subdivision into subclades GIIa and GIIb [22, 34, 37]. This bifurcation reflects a deep evolutionary divergence that correlates with geographic origin rather than clinical syndrome, as strains associated with enteric disease, respiratory disease, and winter dysentery are interspersed across both clades. Indeed, no definitive genetic marker has been identified that reliably distinguishes respiratory from enteric BCoV isolates, suggesting that the virus possesses an intrinsic dual tropism capacity that may be modulated by host factors, quasispecies dynamics, or subtle mutations in receptor-binding domains [33, 53]. This phenomenon is exemplified by the Brazilian strain BR-UEL11, isolated from a respiratory outbreak in feedlot cattle, which clusters phylogenetically with enteric strains associated with calf diarrhea and winter dysentery, exhibiting 98–99% nucleotide identity to those enteric strains [53]. Such findings indicate that Brazilian BCoV populations have evolved from a primarily enteric ancestry to acquire a dual enteric and respiratory tropism, a process that likely occurred through convergent evolution rather than discrete genetic reassortment.

The molecular characterization of the N gene, encoding a highly conserved phosphoprotein essential for viral RNA encapsidation and replication, has provided complementary insights into BCoV phylogenetics. Partial N gene amplification targeting a 172-base pair fragment has been employed successfully in molecular epidemiological surveys in India, where BCoV was detected in 0.98% of bovine respiratory disease complex (BRDC) cases, with sequence comparison confirming close relatedness to published global strains [1]. In Brazil, phylogenetic analysis of the N gene from BCoV strains circulating in high-production dairy herds positioned the isolates within cluster II, yet the S1 gene analysis revealed that these strains formed a distinct branch, tentatively designated genotype #15, ancestrally divergent from both prototype vaccine strains and previously characterized Brazilian enteric strains [4]. This discordance between N gene and S gene phylogenies is a hallmark of coronavirus evolution, reflecting the differential rates of evolutionary change and recombination events that shape the viral genome. The N gene is generally considered more conserved than the S gene, making it a reliable target for broad-spectrum diagnostic assays; however, it is not immune to variation. The Chinese isolate BCoV NXWZ2310, belonging to the GIIb genotype, harbors a notable three-amino-acid deletion (NΔ3) within the serine-rich region of the N protein, a domain implicated in RNA binding and subcellular localization [6]. This deletion, while not altering the overall cluster assignment, may influence viral fitness or pathogenicity, as the NXWZ2310 strain induced severe respiratory and digestive disease in experimentally infected calves, with viral RNA loads reaching 10⁶ copies/mL in nasal and rectal swabs.

The hemagglutinin-esterase (HE) gene, encoding a second surface glycoprotein unique to betacoronaviruses of subgroup A, serves as an additional phylogenetic marker. Complete HE gene sequencing of Korean BCoV strains isolated from diarrheic calves between 2017 and 2018 demonstrated that all 16 isolates belonged to group GIIa, clustering with Korean strains isolated after 2000, whereas strains isolated before 2000 belonged to group GI [34]. This temporal shift suggests a population replacement event that may be linked to drift in receptor-binding preferences or immune evasion. The HE protein functions as a receptor-destroying enzyme with sialate-O-acetylesterase activity, facilitating viral release from sialic acid receptors on host cells. Mutations in the HE active site or substrate-binding pocket could alter the balance between receptor binding and destruction, thereby influencing tissue tropism and transmissibility, though direct experimental evidence linking specific HE polymorphisms to respiratory versus enteric tropism remains limited.

Beyond structural protein genes, the non-structural protein nsp14 has emerged as a critical determinant of BCoV pathogenesis at the molecular level. Nsp14 encodes an exoribonuclease (ExoN) proofreading function, which enhances replication fidelity and facilitates the maintenance of the large coronavirus genome, as well as a guanine-N7-methyltransferase activity involved in cap modification. However, recent work has illuminated an additional, immunomodulatory role for BCoV nsp14: it promotes viral replication by degrading TNF receptor-associated factor 3 (TRAF3), a central adaptor protein in the interferon-β (IFN-β) induction pathway [19]. Mechanistically, nsp14 recruits the E3 ubiquitin ligase STUB1 to ubiquitinate TRAF3, which is subsequently recognized by the cargo receptor Tollip and delivered for autophagic degradation. This process effectively suppresses the host innate immune response, allowing the virus to replicate to higher titers. Notably, this represents a new mechanism of immune evasion for BCoV, and the nsp14-TRAF3 axis may be a target for future therapeutic interventions. The existence of such strain-specific differences in nsp14 function, potentially linked to polymorphic residues, remains an open question that warrants investigation through reverse genetics approaches.

The phylogenetic diversity of BCoV is not merely a static reflection of geographic clustering but is actively shaped by recombination, episodic selective pressure, and population dynamics. A comprehensive phylodynamic analysis of complete genome and S gene sequences revealed that the spike gene undergoes significant positive selection, predominantly episodic and concentrated on surface-exposed residues, consistent with immune-driven evolution [37]. The study further identified compensatory mutations, which maintain protein structural integrity while allowing antigenic diversification. Importantly, the geographic spreading pattern of BCoV is strongly mirrored by global cattle trade networks, with two primary clusters emerging: a European cluster characterized by a dense and rapid migration network, and an American–Asian cluster where the United States acts as the primary source of viral exportation [37]. This pattern underscores the role of human-mediated animal movement in disseminating viral diversity, a scenario that the Food and Agriculture Organization (FAO) has repeatedly highlighted as a critical risk factor for emerging infectious diseases.

Within specific geographic regions, the phylogenetic landscape continues to evolve. In Japan, BCoV strains identified from 2020 to 2022 in Chiba Prefecture were classified into Japan G3 or G4 genotypes based on the polymorphic region of the spike gene, contradicting earlier assumptions that the G3 genotype had gone extinct in the country [2]. This finding indicates that multiple genotypes can coexist and cocirculate, potentially sustained by different cattle cohorts or management systems. Earlier Japanese surveys from 2016 to 2018 documented that 21.2% of respiratory-diseased cattle were BCoV-positive, with viral loads 4.7-fold higher in diseased animals than in asymptomatic ones, and phylogenetic analysis revealed that Japanese strains formed an individual lineage distinct from those in other countries, suggesting endemic evolution in relative isolation [27]. Similarly, in China, the BCoV strain NXWZ2310 and the isolate from Inner Mongolia (strain not yet formally designated) both clustered within the GIIb subgroup, alongside other contemporary Chinese strains, but the Inner Mongolian isolate exhibited high S gene homology (approximately 98–99%) with the yak-derived strain QH1 (MH810151.1), indicative of potential interspecies transmission events between cattle and yaks [22]. This genetic affinity raises important questions regarding the role of wild and semi-domesticated ruminants as reservoirs or bridging hosts for BCoV, a topic with direct relevance to the WOAH guidelines on surveillance at the livestock-wildlife interface.

The zoonotic potential of BCoV, while historically underappreciated, has garnered renewed attention in the context of the SARS-CoV-2 pandemic. BCoV and human coronavirus OC43 (HCoV-OC43) share a common ancestor estimated to have diverged approximately 150 years ago, and contemporary BCoV strains exhibit 96.4–97.1% nucleotide identity and 96.9–98.5% amino acid identity with HCoV-OC43 in the RNA-dependent RNA polymerase (RdRp) gene [9]. Furthermore, the first linear B-cell epitope identified on the BCoV N protein, spanning residues 380YQQQDG385, is 100% conserved with HCoV-OC43 and canine respiratory coronavirus (CRCoV) but exhibits remarkably low homology with other betacoronaviruses [20]. This epitope conservation suggests a shared ancestry and potential for cross-species transmission, and it provides a molecular basis for the historical serological cross-reactivity observed between BCoV and HCoV-OC43. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have both emphasized the importance of understanding animal coronavirus diversity to preempt zoonotic emergence, and BCoV serves as a compelling model for studying the molecular determinants of host range expansion. The World Organisation for Animal Health (WOAH) further recommends that BCoV be included in integrated One Health surveillance frameworks, particularly given its high prevalence in cattle populations worldwide.

In summary, the molecular characterization and phylogenetic diversity of BCoV strains reveal a virus that is simultaneously conserved and variable, constrained by essential functional domains yet remarkably adaptable in the face of host immune pressure and geographic dispersal. The structural protein genes, particularly S and N, serve as the primary windows into viral evolution, while non-structural proteins like nsp14 illuminate the intricate molecular arms race between virus and host. The global phylogeographic patterns mirror human-driven cattle movements, and the close genetic relationships between BCoV and human coronaviruses underscore the importance of sustained molecular surveillance. Continued efforts to sequence complete genomes from diverse clinical presentations and geographic regions, coupled with functional studies of identified polymorphisms, will be essential to unravel the mechanisms underlying BCoV tropism, pathogenesis, and cross-species transmission.

References

[1] Kamdi B, Singh R, Singh V, Singh S, Kumar P, Kashyap G, et al.. Investigating bovine coronavirus in Indian calves: Incidence, molecular evidence, and pathological role in bovine respiratory disease complex (BRDC). Iranian Journal of Veterinary Research. 2025. DOI: https://doi.org/10.22099/ijvr.2024.48820.7142

[2] Sekine W, Kurahashi K, Matsugo H, Ohira K, Katayama M, Li K, et al.. A survey of bovine coronavirus infections in cattle with respiratory disease in Chiba Prefecture, Japan. Journal of Veterinary Medical Science. 2025. DOI: https://doi.org/10.1292/jvms.25-0423

[3] Socha W, Kołacz P, Rola J. A case of acute respiratory disease associated with Bovine Coronavirus (BCoV) infection in calves at the cattle farm in eastern Poland. Medycyna Weterynaryjna. 2026. DOI: https://doi.org/10.21521/mw.7107

[4] Frucchi APS, Agnol AMD, Bronkhorst D, Beuttemmuller EA, Alfieri A, Alfieri A. Bovine Coronavirus Co-infection and Molecular Characterization in Dairy Calves With or Without Clinical Respiratory Disease. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.895492

[5] Rahe MC, Magstadt DR, Groeltz-Thrush J, Gauger P, Zhang J, Schwartz K, et al.. Bovine coronavirus in the lower respiratory tract of cattle with respiratory disease. Journal of Veterinary Diagnostic Investigation. 2022. DOI: https://doi.org/10.1177/10406387221078583

[6] Li S, Yuan X, Mao L, Cai X, Xu X, Li J, et al.. First isolation of bovine coronavirus with a three-amino-acid deletion in the N gene causing severe respiratory and digestive disease in calve. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1466096

[7] Dhufaigh KN, McCabe M, Cormican P, Cuevas-Gómez I, McGee M, McDaneld T, et al.. Genome Sequence of Bovine Coronavirus Variants from the Nasal Virome of Irish Beef Suckler and Pre-weaned Dairy Calves Clinically Diagnosed with Bovine Respiratory Disease. Microbiology Resource Announcements. 2022. DOI: https://doi.org/10.1128/mra.00821-22

[8] McDaneld T, Workman AM, Chitko-McKown C, Kuehn L, Dickey A, Bennett GL. Detection of Mycoplasma bovirhinis and bovine coronavirus in an outbreak of bovine respiratory disease in nursing beef calves. Frontiers in Microbiomes. 2022. DOI: https://doi.org/10.3389/frmbi.2022.1051241

[9] Virant MJ, Černe D, Petrovec M, Paller T, Toplak I. Genetic Characterisation and Comparison of Three Human Coronaviruses (HKU1, OC43, 229E) from Patients and Bovine Coronavirus (BCoV) from Cattle with Respiratory Disease in Slovenia. Viruses. 2021. DOI: https://doi.org/10.3390/v13040676

[10] Ridpath J, Fulton R, Bauermann FV, Falkenberg S, Welch J, Confer A. Sequential exposure to bovine viral diarrhea virus and bovine coronavirus results in increased respiratory disease lesions: clinical, immunologic, pathologic, and immunohistochemical findings. Journal of Veterinary Diagnostic Investigation. 2020. DOI: https://doi.org/10.1177/1040638720918561

[11] Workman AM, Kuehn L, McDaneld T, Clawson M, Loy JD. Longitudinal study of humoral immunity to bovine coronavirus, virus shedding, and treatment for bovine respiratory disease in pre-weaned beef calves. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-1887-8

[12] Karimi O, Bakhshesh M, Sani MB, Tafti HP. Prevalence of bovine respiratory disease viruses in calves from the central desert of Iran. Veterinary Research Forum. 2025. DOI: https://doi.org/10.30466/vrf.2025.2044527.4522

[13] Bernal JMC, Fernández A, Arnal JL, Baselga C, Zuñiga AB, Fernández-Garyzábal J, et al.. Cluster analysis of bovine respiratory disease (BRD)-associated pathogens shows the existence of two epidemiological patterns in BRD outbreaks.. Veterinary Microbiology. 2023. DOI: https://doi.org/10.1016/j.vetmic.2023.109701

[14] Tang J, Grubbs G, Lee Y, Wu H, Luke T, Egland KA, et al.. Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019. Journal of Infectious Diseases. 2022. DOI: https://doi.org/10.1093/infdis/jiac031

[15] Lachowicz-Wolak A, Klimowicz-Bodys M, Płoneczka-Janeczko K, Bykowy M, Siedlecka M, Cinciała J, et al.. The Prevalence, Coexistence, and Correlations between Seven Pathogens Detected by a PCR Method from South-Western Poland Dairy Cattle Suffering from Bovine Respiratory Disease. Microorganisms. 2022. DOI: https://doi.org/10.3390/microorganisms10081487

[16] Padalino B, Cirone F, Zappaterra M, Tullio D, Ficco G, Giustino A, et al.. Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.627894

[17] Soules K, Rahe MC, Purtle L, Moeckly C, Stark P, Samson C, et al.. Bovine Coronavirus Infects the Respiratory Tract of Cattle Challenged Intranasally. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.878240

[18] Zhang H, Yu Q, Guo R, Zhu Q, Yu J, Zhang Z, et al.. Integrative transcriptomic and proteomic analyses reveal that carbon metabolism and complement system of Madin Darby Bovine Kidney cells are affected by bovine coronavirus infection. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04848-z

[19] Sun H, Liu Y, Yang X, Qin W, Lu X, Wang Y, et al.. Bovine coronavirus Nsp14 protein promotes viral replication by degrading TRAF3 to inhibit interferon production.. Veterinary Microbiology. 2025. DOI: https://doi.org/10.1016/j.vetmic.2025.110708

[20] Zhou Y, Zhang J, Wu H, Zhao S, Ren Y, Chen Q, et al.. First linear B-cell epitope identified on the nucleocapsid protein of bovine coronavirus.. Virology. 2025. DOI: https://doi.org/10.1016/j.virol.2025.110581

[21] Pratelli A, Cirone F, Capozza P, Trotta A, Corrente M, Balestrieri A, et al.. Bovine respiratory disease in beef calves supported long transport stress: An epidemiological study and strategies for control and prevention.. Research in Veterinary Science. 2020. DOI: https://doi.org/10.1016/j.rvsc.2020.11.002

[22] Zhang F, Chai C, Niu R, Diao Y, Zhou Y, Zhang J, et al.. Genetic characterization of bovine coronavirus strain isolated in Inner Mongolia of China. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-024-04046-3

[23] Fahkrajang W, Sudaryatma PE, Mekata H, Hamabe S, Saito A, Okabayashi T. Bovine respiratory coronavirus enhances bacterial adherence by upregulating expression of cellular receptors on bovine respiratory epithelial cells. Veterinary Microbiology. 2021. DOI: https://doi.org/10.1016/j.vetmic.2021.109017

[24] Fulton R. Viruses in Bovine Respiratory Disease in North America. The Veterinary clinics of North America. Food animal practice. 2020. DOI: https://doi.org/10.1016/j.cvfa.2020.02.004

[25] Zhang M, Hill J, Alexander T, Huang Y. The nasal viromes of cattle on arrival at western Canadian feedlots and their relationship to development of bovine respiratory disease.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13873

[26] Geng H, Meng X, Yan W, Li X, Jiang J, Ni H, et al.. Prevalence of bovine coronavirus in cattle in China: A systematic review and meta-analysis.. Microbial Pathogenesis. 2023. DOI: https://doi.org/10.1016/j.micpath.2023.106009

[27] Mekata H, Hamabe S, Sudaryatma PE, Kobayashi I, Kanno T, Okabayashi T. Molecular epidemiological survey and phylogenetic analysis of bovine respiratory coronavirus in Japan from 2016 to 2018. Journal of Veterinary Medical Science. 2020. DOI: https://doi.org/10.1292/jvms.19-0587

[28] Zhu Q, Li B, Sun D. Advances in Bovine Coronavirus Epidemiology. Viruses. 2022. DOI: https://doi.org/10.3390/v14051109

[29] Capik S, McAllister HR, Scott M, Crews ME. Impact of vaccination for respiratory disease on antibody titer responses, health, and performance in beef and dairy cattle (PROQUEST DISSERTATIONS & THESES).. searchRxiv. 2024. DOI: https://doi.org/10.1079/searchrxiv.2024.00499

[30] Capik S, McAllister HR, Scott M, Crews ME. Impact of vaccination for respiratory disease on antibody titer responses, health, and performance in beef and dairy cattle (MEDLINE).. searchRxiv. 2024. DOI: https://doi.org/10.1079/searchrxiv.2024.00496

[31] Cho H, Kim Y, Song J, Cho S, Park M, Kim J, et al.. Experimental intranasal infection reveals broad tissue tropism of bovine coronavirus. Veterinary Research. 2026. DOI: https://doi.org/10.1186/s13567-025-01703-9

[32] Brito BP, Frost M, Anantanawat K, Jaya FR, Batterham T, Djordjevic S, et al.. Expanding the range of the respiratory infectome in Australian feedlot cattle with and without respiratory disease using metatranscriptomics. Microbiome. 2023. DOI: https://doi.org/10.1186/s40168-023-01591-1

[33] Vlasova A, Saif L. Bovine Coronavirus and the Associated Diseases. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.643220

[34] Shin J, Choe S, Park G, Song S, Kim K, An B, et al.. Isolation and Genetic Characterization of a Bovine Coronavirus KBR-1 Strain from Calf Feces in South Korea. Viruses. 2022. DOI: https://doi.org/10.3390/v14112376

[35] Wolff C, Emanuelson U, Ohlson A, Alenius S, Fall N. Bovine respiratory syncytial virus and bovine coronavirus in Swedish organic and conventional dairy herds. Acta Veterinaria Scandinavica. 2015. DOI: https://doi.org/10.1186/s13028-014-0091-x

[36] Diemen PMv, Ramsay AM, Everett HE, Hurley S, Lean F, Núñez A, et al.. Experimental infection of alpacas (Vicugna pacos) with Influenza C and D viruses results in subclinical upper respiratory tract disease. bioRxiv. 2025. DOI: https://doi.org/10.1101/2025.07.28.667103

[37] Franzo G, Drigo M, Legnardi M, Grassi L, Pasotto D, Menandro ML, et al.. Bovine Coronavirus: Variability, Evolution, and Dispersal Patterns of a No Longer Neglected Betacoronavirus. Viruses. 2020. DOI: https://doi.org/10.3390/v12111285

[38] Amoroso M, Lucifora G, Uberti BĎ, Serra F, Luca Gd, Borriello G, et al.. Fatal Interstitial Pneumonia Associated with Bovine Coronavirus in Cows from Southern Italy. Viruses. 2020. DOI: https://doi.org/10.3390/v12111331

[39] Pardon B, Callens J, Maris J, Allais L, Praet W, Deprez P, et al.. Pathogen-specific risk factors in acute outbreaks of respiratory disease in calves. Journal of Dairy Science. 2020. DOI: https://doi.org/10.3168/jds.2019-17486

[40] Lowie T, Jourquin S, Debruyne F, Chantillon L, Hoflack G, Boone R, et al.. Associations of serostatus upon arrival with clinical respiratory disease, lung consolidation and growth in veal calves.. Journal of Dairy Science. 2023. DOI: https://doi.org/10.3168/jds.2023-24218

[41] Ramón AC, Pérez GV, Caballero E, Rosales M, Aguilar D, Vázquez-Blomquist D, et al.. Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection. bioRxiv. 2021. DOI: https://doi.org/10.3390/v14030552

[42] Amoroso M, Lucifora G, Uberti B, Serra F, Domenico A, Cuomo MC, et al.. Fatal Interstitial Pneumonia Caused by Bovine Coronavirus in Cows from Southern Italy. . 2020. DOI: https://doi.org/10.20944/preprints202007.0749.v1

[43] Stokstad M, Klem T, Myrmel M, Oma V, Toftaker I, Østerås O, et al.. Using Biosecurity Measures to Combat Respiratory Disease in Cattle: The Norwegian Control Program for Bovine Respiratory Syncytial Virus and Bovine Coronavirus. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.00167

[44] Hegazy AA, Nakai M, Fuke N, Hussein A, Kondo H, Hirai T. Detection of bovine respiratory disease complex–related pathogens in nasopharynx-associated lymphoid tissue. Journal of Veterinary Diagnostic Investigation. 2025. DOI: https://doi.org/10.1177/10406387251318415

[45] Toftaker I, Ågren E, Stokstad M, Nødtvedt A, Frössling J. Herd level estimation of probability of disease freedom applied on the Norwegian control program for bovine respiratory syncytial virus and bovine coronavirus. Preventive Veterinary Medicine. 2018. DOI: https://doi.org/10.1016/j.prevetmed.2018.07.002

[46] Ambrose R, Blakebrough-Hall C, Gravel J, Gonzalez LA, Mahony T. Characterisation of the Upper Respiratory Tract Virome of Feedlot Cattle and Its Association with Bovine Respiratory Disease. Viruses. 2023. DOI: https://doi.org/10.3390/v15020455

[47] Cusack P. Evaluation of practices used to reduce the incidence of bovine respiratory disease in Australian feedlots (to November 2021).. Australian Veterinary Journal. 2023. DOI: https://doi.org/10.1111/avj.13239

[48] Donbraye E, McLeod L, Chai Z, Lacoste SR, McCarthy E, Hill JE, et al.. Diagnostic sensitivity and specificity of metagenomic sequencing and qPCR for detection of viruses associated with bovine respiratory disease estimated using Bayesian latent class models. Frontiers in Veterinary Science. 2026. DOI: https://doi.org/10.3389/fvets.2026.1704414

[49] Liang Z, Luo R, He Q, Tang C, Zhang Z, Li Y, et al.. Specific and sensitive detection of bovine coronavirus using CRISPR-Cas13a combined with RT-RAA technology. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2024.1473674

[50] Kiser J, Neibergs H. Identifying Loci Associated With Bovine Corona Virus Infection and Bovine Respiratory Disease in Dairy and Feedlot Cattle. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.679074

[51] Zhang M, Hill J, Fernando C, Alexander T, Timsit E, Meer Fvd, et al.. Respiratory viruses identified in western Canadian beef cattle by metagenomic sequencing and their association with bovine respiratory disease. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13172

[52] Toftaker I, Toft N, Stokstad M, Sølverød L, Harkiss G, Watt N, et al.. Evaluation of a multiplex immunoassay for bovine respiratory syncytial virus and bovine coronavirus antibodies in bulk tank milk against two indirect ELISAs using latent class analysis. Preventive Veterinary Medicine. 2018. DOI: https://doi.org/10.1016/j.prevetmed.2018.03.008

[53] Beuttemmuller EA, Alfieri A, Headley SA, Alfieri A. Brazilian strain of bovine respiratory coronavirus is derived from dual enteric and respiratory tropism.. Genetics and Molecular Research. 2017. DOI: https://doi.org/10.4238/gmr16029580

[54] Klem T, Rimstad E, Stokstad M. Occurrence and phylogenetic analysis of bovine respiratory syncytial virus in outbreaks of respiratory disease in Norway. BMC Veterinary Research. 2014. DOI: https://doi.org/10.1186/1746-6148-10-15

[55] Rooij MHv, Schmitz M, Meessen JM, Wouters PAWM, Vrijenhoek M, Makoschey B. Vaccination of calves at day of birth with attenuated vaccines against bovine respiratory syncytial virus, bovine parainfluenza type 3 virus and respiratory bovine coronavirus. Veterinary Vaccine. 2023. DOI: https://doi.org/10.1016/j.vetvac.2023.100014

[56] Hao F, Tao C, Xiao R, Huang Y, Yuan W, Wang Z, et al.. Development of a Multiplex Real-Time PCR Assay for the Detection of Eight Pathogens Associated with Bovine Respiratory Disease Complex from Clinical Samples. Microorganisms. 2025. DOI: https://doi.org/10.3390/microorganisms13071629

[57] Kishimoto M, Tsuchiaka S, Rahpaya SS, Hasebe A, Otsu K, Sugimura S, et al.. Development of a one-run real-time PCR detection system for pathogens associated with bovine respiratory disease complex. Journal of Veterinary Medical Science. 2017. DOI: https://doi.org/10.1292/jvms.16-0489

[58] Hyeon L, Yang D, Park Y, Lee H, Kim H, Hyun B. Evaluation of hemagglutination inhibition test for canine respiratory coronavirus antibodies and seroprevalence in Korean dogs. Korean Journal of Veterinary Research. 2023. DOI: https://doi.org/10.14405/kjvr.20230037

[59] Berezenko A, Nedosekov V, Godovskiy O, Ltd B. Isolation of bovine coronavirus (BCov) in cell cultures. Naukovì dopovìdì Nacìonalʹnogo unìversitetu bìoresursiv ì prirodokoristuvannâ Ukraïni. 2021. DOI: https://doi.org/10.31548/dopovidi2021.04.001

[60] Ruiz M, Puig A, Bassols M, Fraile L, Armengol R. Influenza D Virus: A Review and Update of Its Role in Bovine Respiratory Syndrome. Viruses. 2022. DOI: https://doi.org/10.3390/v14122717